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ABSTRACT
Obesity has become a worldwide epidemic and is a major risk factor for metabolic syndrome. It
is believed that cellular oxidant stress plays a key role in both the development and maintenance
of obesity as well as its associated comorbidities such as diabetes, cardiovascular disease, and
nonalcoholic steatohepatitis (NASH). We have previously reported that systemic administration
of pNaKtide, which targets the Na/K-ATPase oxidant amplification loop was able to decrease
oxidative stress and adiposity in mice fed a high fat and fructose supplemented western diet
(WD). As adipocytes are believed to play an active role in the development of obesity and its
related comorbidities, we examined whether lentiviral-mediated adipocyte-specific expression of
NaKtide, the portion of pNaKtide derived from the α1 Na/K-ATPase N domain without the TAT
leaders sequence used to make pNaKtide cell permeant, could have a similar ameliorative effect.
To test this hypothesis, studies were first performed in isolated murine preadipocytes, 3T3-L1
cells; it was found that specific activation of Na/K-ATPase signaling (with the cardiotonic
steroid ouabain which is specific to the Na/K-ATPase) significantly increased adipogenesis in
3T3-L1 cells in the presence of adipogenic medium, and pNaKtide administration attenuated
oxidative stress and lipid accumulation. When administered through a lentiviral construct,
NaKtide showed a similar decrease in oxidative stress. Complementary in vivo studies were
performed as well. C57BL6 mice fed a WD activated adipocyte Na/K-ATPase signaling and
increased adiposity, systemic oxidative stress and insulin resistance as well as induced
development of NASH. Also of note, WD increased the plasma levels of leptin, IL-6 and TNFα
along with decreased locomotor activity, expression of the D2 receptor and tyrosine hydroxylase
in defined brain regions as well as markers of neurodegeneration including neuronal apoptosis.
Selective adipocyte expression of NaKtide in these mice fed a WD attenuated all of these

xiv

changes including the brain biochemical alterations and behavioral adaptations. These data
suggest that adipocyte derived cytokines play an essential role in the development of obesity
induced by a WD and that targeting the adipocyte Na/K-ATPase oxidant amplification loop
(NKAL) may serve as an effective therapeutic strategy.

xv

CHAPTER 1
INTRODUCTION
Na/K-ATPase: History and Signaling Function
The Na/K-ATPase is an enzyme that is found in the plasma membrane of all animal cells
and holds several important cellular responsibilities (Skou, 1957, 1986). It is responsible for not
only the movement of sodium (Na+) and potassium (K+) across their ion gradients at the expense
of adenosine triphosphate (ATP), but in more recent years has been implicated as a signaling
transducer that interacts with multiple protein kinase cascades and is a factor in many disease
states [reviewed in (Aperia, 2007; Z. Xie & Cai, 2003)].
Before its discovery, the existence of the Na/K-ATPase had been speculated for years.
Many important findings occurred that finally led to its discovery in 1957(Skou, 1957). Carl
Schmidt demonstrated the existence of a Na+/K+ concentration gradient across the cell membrane
and Rudolph Heidenhain proposed a “microscopic steamship” in the membrane that was capable
of maintaining this gradient(Heidenhain, 1894; Zaleski, 1894) . Ernest Overton demonstrated
that muscle cells had active transport mechanisms that allowed cells to move Na+ and K+ across
the cell membrane, via energy consumption (Overton, 1899, 1902). Heppel and Steinbach
confirmed these findings in muscle cells using radioactive isotopes, and this was further
confirmed by US scientists who found that cardiac glycosides (such as ouabain) were specific
inhibitors of active transport in red blood cells (RBCs) (Heppel, 1940; Steinbach, 1940). ATP
dependent potassium uptake further supported and linked the transport system to membrane
bound ATPase sensitive to cardiac glycosides or cardiotonic steroids (CTS) (Skou, 1986).
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In 1957, while doing anesthesia research in crab leg nerves, Jens Christian Skou found
that the Na/K-ATPase was at its most active when combined with the correct combination of
Na+, K+, and magnesium (Mg+) (Skou, 1957; Skou & Esmann, 1983, 1992). During the same
time, Robert Post (in the US) found that the Na/K-ATPase is responsible for moving 3 Na+ and 2
K+ ions across the cell membrane in RBCs; the first discovery of the Na/K-ATPase was due to
Skou, but was confirmed by Post (Post, 1969).
Around the same time as these discoveries, renal physiologists and cell biologists had
developed a kidney Na/K-ATPase purification protocol. From this, we understand that the Na/KATPase exists in a dynamic state of conformation equilibrium; this is vital for the ability to
convert ATP hydrolysis to binding and movement of ions across the plasma membrane (Blanco,
DeTomaso, Koster, Xie, & Mercer, 1994; Blanco, Koster, Sanchez, & Mercer, 1995) . Digitalis
specific inhibition of the Na/K-ATPase was recognized in the late 50’s; in cardiac myocytes
inhibition of Na/K-ATPase activity by cardiotonic steroids increases intracellular Na+
concentration, which leads to accumulation of intracellular calcium (Ca2+) via the Na+/ Ca2+
exchanger (Blanco et al., 1994; Blanco et al., 1995).
Molecular cloning of sheep kidneys in 1985 by G.E. Shull, Schwarts, and Linguel led to
further information about the complexity of the Na/K-ATPase; their work indicated the
possibility of more than one Na/K-ATPase isoform (G. E. G. Shull, J.; Lingrel, J.B, 1986; G. E.
S. Shull, A.; Lingrel, J.B, 1985). Sweadner further discovered there are four different isoforms
of the Na/K-ATPase in rat tissues (Sweadner, 1989). These isoforms are expressed in a tissuespecific manner, but the tertiary structure of each isoform is relatively the same: α1 is expressed
in virtually all tissues (especially endothelium), α2/α3 are expressed in cardiac myocytes,
skeletal muscle, and neurons, and α4 is primarily found in the testis and is involved with sperm
2

motility (Blanco, Melton, Sanchez, & Mercer, 1999; Sweadner, 1989; Z. Xie & Cai, 2003).
Finally, in 1987 Marks and Seeds confirmed the previous discovery regarding Na/K-ATPase
isoforms(Marks, 1978).
Between 1987 and 1990, the crystal structure of the Na/K-ATPase was determined. It
contains 10 transmembrane helices, with both N and C domains in the cytoplasm, and 2 noncovalently linked α and β subunits (Laursen, Yatime, Nissen, & Fedosova, 2013; Morth et al.,
2007; Nyblom et al., 2013; Z. Xie, 2003). The α subunit consists of the actuator domain, the
second cytosolic domain, the phosphorylation domain and the nucleotide binding domain, and
the β subunit is essential for the formation of a competent pump [reviewed in (Blanco, 2005; Z.
Xie, 2003; Z. Xie & Askari, 2002)].
During the early 21st century it was determined that the Na/K-ATPase belongs to a class
of ion pumps known as the P-Type ATPases. This family of ATPases is also known as the E1/E2
ATPases and are known for their role in carrying out many fundamental biological and
physiological processes; the Na/K-ATPase is a unique P-Type ATPase in its ability to bind CTS,
such as ouabain (Jorgensen & Andersen, 1988; Kaplan, 2002; Lutsenko & Kaplan, 1995; Z. Xie
& Cai, 2003).
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Years of research has shown that through binding interactions between the α1 subunit of
the Na/K-ATPase and Src, a signaling cascade is produced that has various effects on both
protein and lipid cascades, responsible for cell growth and cellular homeostasis (Z. Li et al.,
2009; Z. Li & Xie, 2009; Z. Xie, 2003; Z. Xie & Cai, 2003; Z. Xie et al., 1995; Z. Xie et al.,
1999). Specifically, the Na/K-ATPase α1 subunit and Src are bound at multiple locations, seen in
Figure 1 [subject reviewed in (Tian et al., 2006; Y. Wang et al., 2014; Z. Xie, 2003; Z. Xie &
Askari, 2002)]. Under normal physiological conditions, interaction at both the kinase domain and
SH2 domain of Src with the Na/K-ATPase α1 subunit ND1 and CD2 segments keeps the
molecule in an E1 or “inactive” state (Jorgensen & Andersen, 1988; Z. Xie, 2003; Z. Xie &
Askari, 2002; Z. Xie & Xie, 2005).

Figure 1. Na/K-ATPase α1 and Src Interacting Domains.
Specific binding at multiple locations on both the α1 subunit and c-Src are responsible for a
signaling cascade that has various effects on protein and lipid cascades and impacts cell growth
and cellular homeostasis.
In cell culture models, ouabain binding to the Na/K-ATPase at its specific binding site
causes two things to occur: increased intracellular Na+ leads to an inhibition of pumping and
Na/K-ATPase associated c-Src is activated (Aizman, Uhlen, Lal, Brismar, & Aperia, 2001; Haas,
Askari, & Xie, 2000; J. Liu et al., 2000; Peng, Huang, Xie, Huang, & Askari, 1996). This
phosphorylation of Na/K-ATPase-bound Src stimulates protein tyrosine phosphorylation (at
4

tyrosine residue 418 (Tyr 418) on Src) and results in the downstream signaling cascade; this
pushes the pump into an E2 or “active” state (Figure 2). (Haas et al., 2000; Jorgensen &
Andersen, 1988; Z. Li & Xie, 2009). Ouabain activates Na/K-ATPase associated Src at Tyr 418,
this is kind of a repeat of previous sentence increases Src binding to the Na/K-ATPase, and this
activation is the crucial first step in the downstream signaling cascade (Z. Xie, 2003; Z. Xie &
Askari, 2002).

Figure 2. Na/K-ATPase Signaling Cascade.
When stimulated by cardiotonic steroids (CTS) such as ouabain, c-Src bound to the
Na/K-ATPase is phosphorylated; this phosphorylation activates the signaling cascade.

The Na/K-ATPase has multiple signaling partners and its downstream signaling/protein
tyrosine effects have been implicated in many signaling pathways and disease states (Z. Xie,
2003; Z. Xie & Askari, 2002; Yan et al., 2016). Xie et al proposed that there are three potential
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chemical classes (pathological and physiological) that can serve as Na/K-ATPase ligands:
cardiac glycosides, chemical modifiers, and ionic alterations(Z. Xie, 2003).
Cardiac glycosides are a class of organic compounds that increase contraction rate in the
heart by increasing calcium alterations via interactions with the Na/K-ATPase (Oweis et al.,
2006; Pierre & Xie, 2006; Z. Xie & Xie, 2005). Cardiac glycosides can be exogenous, like the
commonly used heart failure medication digoxin, but they have also been found to be
endogenous. Ouabain is known best for its role in modulating blood pressure and its role in
hypertension; it is regulated by hormones such as adrenocorticotropic hormone and angiotensin
II (Ang II) (Blaustein & Hamlyn, 2010; Dostanic et al., 2005; Z. Li & Xie, 2009; Z. Xie, 2003).
As a specific ligand, ouabain exerts very significant effects on the Na/K-ATPase, such as
inhibiting ion-pumping activity as well as activating Src associated with the Na/K-ATPase (Z. Li
& Xie, 2009; Z. Xie, 2003). Na/K-ATPase associated c-Src, once active, then converts and
amplifies the ligand binding signal to cause significant increases in protein tyrosine
phosphorylation and increases the activity of downstream kinase activity(Z. Xie, 2003). It is
known that in low doses, ouabain induces substantial endocytosis of the Na/K-ATPase in a Src
dependent manner; the endocytosis and subsequent recycling of the pump is a necessary process
that is mediated by Src and caveolin-1(J. Liu et al., 2004; J. Liu et al., 2005; Z. Xie, 2003).
Chemical modifiers that irreversibly or reversibly alter Na/K-ATPase can also act as
ligands(Z. Xie, 2003). The most prominent of these examples is reactive oxygen species (ROS).
ROS are chemically reactive, and contain oxygen. There are several examples including
peroxides, superoxide, and hydroxyl radicals, among more (J. Liu et al., 2000; Lushchak, 2014;
Sodhi et al., 2015; Z. Xie & Cai, 2003; Z. Xie et al., 1999; Yan et al., 2013; Yan et al., 2016).
ROS are a natural byproduct of normal oxygen metabolism, and have roles in cell signaling and
6

homeostasis. During times of “stress” (low oxygen levels, starvation, inflammation, etc.) ROS
levels can increase dramatically and lead to cellular damage (Furukawa et al., 2004; Jakus, 2000;
Sodhi et al., 2017; Srikanthan, Feyh, Visweshwar, Shapiro, & Sodhi, 2016; Srikanthan, Shapiro,
& Sodhi, 2016; Vincent & Taylor, 2006). Mitochondria are potent ROS producers, and give off
ROS during the production of ATP in the electron transport chain (Halliwell, 1989; Harman,
1992; Yan et al., 2013). The free radical oxygen produced during the electron transport chain is
normally converted to water, but in a small number of electrons passing through the chain, the
free radical is released. In disease states such as obesity, an increased inflammatory profile is
implicated with increased ROS (Fernandez-Sanchez et al., 2011; Furukawa et al., 2004;
Lafontan, 2014; Le Lay, Simard, Martinez, & Andriantsitohaina, 2014). When an increased level
of ROS is present, it can damage RNA/DNA, increase lipid peroxidation, and oxidize amino
acids in proteins (Halliwell, 1989; Jakus, 2000). Ouabain binding can increase mitochondrial
ROS production(J. Liu et al., 2004). This increase in ROS production can lead to abnormal
signaling, desensitization of the Na/K-ATPase to stop signals, and throws the Na/K-ATPase into
what is known as an oxidant amplification loop; this loop has been implicated in several disease
states over the last few years (J. Liu et al., 2016; Sodhi et al., 2015; Sodhi et al., 2018; Sodhi et
al., 2017).
To further understand the interaction between α1 and c-Src, the domain between the two
was mapped. This mapping led to the discovery of two separate binding domains that are
important for c-Src targeting and the signaling cascade, seen above in Figure 1(Z. Li et al.,
2009). Specifically, the SH2 and KD (kinase domain) of c-Src and the CD2 and ND1 segment of
α1 are necessary for proper signaling and binding. The SH2 domain is crucial for the targeting of
c-Src, but the real signaling power comes from the interaction between the KD of c-Src and ND1
7

segment of α1(Z. Li et al., 2009; Z. Xie, 2003). When bound, the α1/c-Src complex is inactive,
and takes on an E1 conformation; when stimulated by ouabain or ROS, the bond between KD
and ND1 is broken, pushing the receptor complex into an E2 state and allowing the signaling
cascade to begin (Blanco, 2005; Tian et al., 2006; Z. Xie et al., 1995). Tyr 418 on c-Src is
phosphorylated and therefore activated. This allows for phosphorylation on other proteins such
as MAPK, ERK1/2, IP3, as well as other proteins in various pathways that have yet to be
elucidated (Aperia, 2007; Z. Xie, 2003).
Mapping of these domains led to the identification of a 20 amino acid sequence that
could inhibit c-Src activation, called NaKtide. This peptide was derived from the ND1 segment,
and therefore mimics binding to the KD, which prevents c-Src phosphorylation, inhibiting the
signaling cascade (Z. Li et al., 2009).
NaKtide ranges from serine residue 415 (Ser 415) to glutamine residue 434 (Gln 434) and
acts on Na/K-ATPase c-Src complexes outside of the cell membrane (it is not cell permeable) (Z.
Li et al., 2009). In order to further explore this relationship, a cell-permeable version of NaKtide
was created, pNaKtide. pNaKtide functions similarly to NaKtide, by targeting the receptor
complexes close to the plasma membrane inside the cell; its cell permeability comes from a 13
amino acid twin-arginine translocation (TAT) leader sequence, which makes the peptide positive
(Z. Li et al., 2009). Both NaKtide and pNaKtide act on c-Src but the major difference lies in it is
cell membrane permeable or not. (Z. Li et al., 2009).
For close to a decade pNaKtide has been used as a specific antagonist of Na/K-ATPase
signaling. It seems to be an ideal candidate for treatment of obesity, inflammation, nonalcoholic
steatohepatitis (NASH), uremic cardiomyopathy, and seems to reverse the aging process(Bartlett,
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Miller, Thiesfeldt, Lakhani, Khanal, et al., 2018; J. Liu et al., 2016; Sodhi et al., 2015; Sodhi et
al., 2018; Sodhi et al., 2017). Recently, pNaKtide has been shown to decrease c-Src activation,
carbonylation and damage from ROS, as well as decreasing adiposity and other biomarkers (J.
Liu et al., 2016; Sodhi et al., 2017). Previous data has shown a potentially (and slightly) toxic
effect for NaKtide, which was ameliorated with development of pNaKtide (Z. Li et al., 2009).
Adipocyte Biology
Obesity is currently named as the most important noncommunicable disease. In 1990, the
prevalence of obesity was no more than 15% across the United States; as of 2010, the incidence
is no less than 20%, with some states creeping towards the 30% or higher mark (Courtesy of the
CDC). It is a multifactorial disease, and in more recent years has been characterized as a low
grade chronic inflammatory disease that is linked to metabolic disorders including Type 2
diabetes and insulin resistance, nonalcoholic steatohepatitis (NASH), cardiovascular disease, and
has more recently been implicated in neurodegenerative disorders (Figure 3) (Kothari et al.,
2017; Sodhi et al., 2015; Sodhi et al., 2017; Srikanthan, Shapiro, et al., 2016; E. Stolarczyk,
2017). Adipose tissue was previously thought to only be an energy reservoir, but research has
shown that it plays a larger role in whole body homeostasis; adipose tissue is a secretory
endocrine organ that is responsible for the secretion of between 50 and 100 cytokines, hormones,
and proteins that impact the functionality of cells and tissues everywhere in the body (GomezHernandez, Beneit, Diaz-Castroverde, & Escribano, 2016; Greenberg & Obin, 2006).
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Figure 3. Obesity and Related Comorbidities.
Obesity has been classified as a low grade chronic inflammatory disease that is linked to
metabolic disorders including Type 2 diabetes and insulin resistance, nonalcoholic
steatohepatitis (NASH), cardiovascular disease, and has more recently been implicated in
neurodegenerative disorders
White adipose tissue is classically spherical in shape, ranging in size from 25 uM to 200
uM. The nucleus is flat and the cytoplasm is thin. The majority of the cell’s size (~90%) is taken
up by a single large lipid droplet; there are limited mitochondria and small amounts of smooth
and rough endoplasmic reticulum. The adipocytes are held together by poorly vascularized and
innervated connective tissue. Obesity triggers accumulation of lipids in adipocytes, triggering
cellular stress, and activating apoptotic and inflammatory pathways (Greenberg & Obin, 2006;
Lumeng, Bodzin, & Saltiel, 2007). Adipocytes are one part of what makes up adipose tissue.
White adipose tissue is made up of adipocytes, macrophages, leukocytes, fibroblasts, cell
progenitors, and endothelial cells; this diverse mix gives evidence to the vast array of hormones,
cytokines, and proteins that are secreted by white adipose tissue(Gil, Olza, Gil-Campos, GomezLlorente, & Aguilera, 2011; Gomez-Hernandez, Beneit, Diaz-Castroverde, et al., 2016). Adipose

10

tissue macrophages (ATMs) accumulate in adipose tissue with adiposity. ATMs are a prominent
source of proinflammatory cytokines that block insulin action in the adipocytes and are
augmenters of ROS; in fact, ATMs are responsible for most of the cytokine production from
dysfunctional adipose tissue (Greenberg & Obin, 2006; Lumeng et al., 2007).
Macrophage activation has been defined across two polarization states, and in normal
conditions, macrophages are likely activated as a continuum between the two states: the
classically activated M1 macrophages and the alternatively activated M2 macrophages
(Hausman, DiGirolamo, Bartness, Hausman, & Martin, 2001; Lumeng et al., 2007). M1
macrophages are induced by proinflammatory mediators and have enhanced proinflammatory
cytokine production (tumor necrosis factor α (TNFα) and interleukin-6 (IL-6)) and generate
significant amounts of ROS (Hausman et al., 2001; Lumeng et al., 2007). M2 macrophages, on
the other hand, are generated by exposure to interleukin-4 (IL-4) and interleukin-13 (IL-13), and
have a higher expression level of anti-inflammatory cytokines compared to pro-inflammatory
cytokines (Greenberg & Obin, 2006; Lumeng et al., 2007). Exposure to high fat diet (HFD)
feeding causes a phenotypic switch from M2 to M1 macrophages, switching the cell from an
anti-inflammatory state to a pro-inflammatory state; this shows that ATMs are a significant
contributor to inflammation in obesity (Greenberg & Obin, 2006; Lumeng et al., 2007; Medh,
2002).
The inflammatory response in obesity appears to be triggered by, and reside, in the
adipose tissue itself (Wellen & Hotamisligil, 2003). Obesity features both metabolic and
inflammatory pathway abnormalities, through dysregulated production of the released factors, or
adipokines (Sodhi et al., 2015; Sodhi et al., 2017; Wellen & Hotamisligil, 2003).
Hypertriglyceridemia, hyperglycemia, and oxidative stress increases plasma free fatty acids
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(FFA) in circulation, which further increases oxidative stress; these events can trigger
inflammatory responses in other areas of the body, including the liver (via the portal vein) and
the brain (through systemic circulation) (Gomez-Hernandez, Beneit, Diaz-Castroverde, et al.,
2016; Sodhi et al., 2015; Sodhi et al., 2017; Wellen & Hotamisligil, 2003). ROS production
increases in parallel with fat accumulation. ROS upregulates expression of proinflammatory
cytokines and macrophage chemoattractive molecules, which stimulates the production of more
ROS (Srikanthan, Shapiro, et al., 2016; Wellen & Hotamisligil, 2003). This leads to a vicious
cycle of ROS production that throws the already imbalanced pro/anti-oxidant system into further
distress, leading to an increase in systemic oxidative stress and maintenance of the obese
phenotype. This increase in ROS also leads to hyperglycemia and hyperlipidemia.
Hyperglycemia is caused when ROS activates polyol and hexosamine pathways, which leads to
the production of advanced glycation end products and increases in diacylglycerol synthesis
(Boyer et al., 2015; Le Lay et al., 2014). Hyperlipidemia results from increased lipid oxidation.
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Figure 4. Differences in adipose tissue in lean vs obese scenario.
Adipose tissue contains a milieu of components, including adipocytes, macrophages,
leukocytes, fibroblasts, cell progenitors, and endothelial cells; this diverse mix gives
evidence to the vast array of hormones, cytokines, and proteins that are secreted by white
adipose tissue. The inflammatory response characteristic of obesity appears to be triggered
by and reside in the adipose tissue itself.

TNFα and IL-6 are local inflammatory markers generated by obesity. TNFα levels in
plasma are positively correlated with the size of adipose depots, and increased TNFα levels are
linked to development of insulin resistance(Gomez-Hernandez, Beneit, Diaz-Castroverde, et al.,
2016). Under ordinary conditions, TNFα activates lipolysis and inhibits the expression of
lipoprotein lipase (LPL) and glucose transporter type 4 (GLUT4) as a mechanism to reduce
excessive size of adipose tissue depots. LPL is an important factor in lipid metabolism, and
studies have shown that relative levels of LPL activity in adipose tissue determine whether lipids
are stored or utilized (Garcia-Arcos et al., 2013; Mead, Irvine, & Ramji, 2002). Increased insulin
in the blood, after increased presence of glucose in the blood and activation of glucose receptors,
causes an increase of glucose uptake into cells through GLUT4. Abnormal levels of TNFα could
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be accountable for the metabolic alterations seen in obesity, including abnormal action of LPL
and GLUT4 (Garcia-Arcos et al., 2013). Further, TNFα increases FFA levels, induces insulin
resistance, and has an inhibitory effect on insulin action in the liver; this causes an increase in
hepatic glucose production (Cawthorn & Sethi, 2008; Greenberg & McDaniel, 2002; Lumeng et
al., 2007). Activation of the nuclear factor kappa-light-chain-enhancer of activated B cells
(NFκB) pathway in adipose tissue may also contribute to metabolic abnormalities influenced by
TNFα (Gomez-Hernandez, Beneit, Diaz-Castroverde, et al., 2016; Kothari et al., 2017).
Increased FFA are known to promote insulin resistance in the muscle by secondary alterations in
phosphoproteins (perilipins) found on the surface of the adipocyte(Greenberg & Obin, 2006).
TNFα inhibits insulin-stimulated autophosphorylation of the insulin receptor, and
phosphorylation of the insulin receptor substrate 1 (IRS1) in vivo; regulation of glucose
transporter number and activity, modulation of steps downstream from IRS1, and even inhibiting
transcription of IRS1 and GLUT4 may be part of the complex process (Hotamisligil, Arner,
Caro, Atkinson, & Spiegelman, 1995; Z. Liu et al., 2012; E. Stolarczyk, 2017). TNFα has been
implicated in activation of signaling transduction pathways leading to proapoptotic effects in
virtually all tissues, and has even more recently been connected to neurodegenerative disorders
and progression of the insulin resistant component of Alzheimer’s disease (Cawthorn & Sethi,
2008; Kothari et al., 2017).
IL-6 is another proinflammatory cytokine implicated in the negative prognosis of obesity
and other diseases. Its role in adiposity is similar to TNFα; it sports pro and anti-inflammatory
properties and increases insulin resistance by inhibiting LPL(E. Stolarczyk, 2017). This
inhibition leads to increases in fat cell size as they store more lipids. IL-6, like TNFα, is secreted
primarily by macrophages in adipocytes. TNFα and IL-6 are some of the few cytokines that are
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able to cross the blood brain barrier, and some studies have shown that they are capable of
making the blood brain barrier permeable to other cytokines, making it a factor in increased
inflammation in neurodegenerative disorders (Greenberg & Obin, 2006; Youdim, Lavie, &
Riederer, 1994).
Leptin, adiponectin, and Ang II are protein hormones that are associated with the
regulation of body weight and vascular function; unlike IL-6 and TNFα, whose functions in
obesity are very similar, these three protein hormones have very different roles. Ang II has a
positive effect on differentiation of adipose tissue, and regulates adiposity due to its lipogenic
actions; it is a pro-oxidant molecule and under abnormal conditions (i.e. increased adiposity in
obesity) it stimulates NADPH oxidases and activates MAPK and protein kinase pathways,
leading to increases of ROS (Cao, Sodhi, Inoue, et al., 2011; Gomez-Hernandez, Beneit, DiazCastroverde, et al., 2016; Srikanthan, Shapiro, et al., 2016). Plasma Ang II has been shown to
increase with increasing body weight, and in addition to its role in adiposity, it has been shown
to play a critical role in cardiovascular diseases (Cao et al., 2012; Cao, Sodhi, Inoue, et al.,
2011).
Both adiponectin and leptin are important hormones with central and peripheral effects
on metabolism and energy balance by reducing circulating FFA (Greenberg & Obin, 2006).
Adiponectin is only produced by adipocytes, and enhances insulin sensitivity in muscle and liver
by increasing FFA oxidation and decreasing glucose production; it is inversely related to
adiposity, and as lipids increase and the adipocyte grows, adiponectin release is decreased
(therefore decreasing its beneficial effects) (Greenberg & Obin, 2006; E. Stolarczyk, 2017).
Adiponectin is also responsible for suppressing M1 macrophage activation and promoting M2
proliferation(E. Stolarczyk, 2017).
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Leptin is primarily produced by adipocytes, but some leptin can also be produced by
other tissues (it has been argued that these sources of leptin are more local mediators than
systemic, and the major source of leptin is adipocytes) (Trayhurn & Bing, 2006). Leptin has a
direct action on the hypothalamus to reduce food intake; levels rise significantly in obesity and
targeted tissues become resistant to its effects. It also has a role in regulating the immune
response, as an inflammatory molecule, and can activate adaptive immune cells ( such as B and
T cells) in different nutritional states (obese, malnourished, etc.) (E. Stolarczyk, 2017). Leptin
exerts central effects on appetite and peripheral effects on energy expenditure; in fact,
significantly increased leptin (as seen in obesity) inhibits dopamine receptor 2 signaling and
transcription in the brain, leading to decreased dopamine receptors, decreased dopamine and
tyrosine hydroxylase, and a decrease in physical activity (Fulton et al., 2006; Ishibashi et al.,
2012; Opland, Leinninger, & Myers, 2010; Perry et al., 2010). Abnormal levels of leptin also
promote inflammation and lipid peroxidation, leading to an increase in oxidative stress in obese
states (Srikanthan, Shapiro, et al., 2016). Low adiponectin and high leptin seen in obesity are
associated with a significantly increased risk for metabolic and cardiovascular complications
associated with obesity, including hypertension, Type 2 diabetes, NASH, and
neurodegeneration(Gomez-Hernandez, Beneit, Diaz-Castroverde, et al., 2016; Park et al., 2010;
Sodhi et al., 2017).
Traditionally, fat can be broken down into two categories, and there are many differences
between the two. White fat has been discussed extensively above, and is what is more typically
implicated in obesity and metabolic syndrome. Brown fat is typically found in the
supraclavicular and spinal region of infants and rodents, but studies have shown that human
adults also have brown fat specific depots (Gomez-Hernandez, Beneit, Diaz-Castroverde, et al.,
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2016). Whereas white fat is primarily an energy storing molecule, brown fat can dissipate stored
chemical energy as heat (therefore giving it an energy releasing phenotype)(Alvarez et al., 1995;
Ballinger & Andrews, 2018). Brown fat is richly innervated and uses the mitochondrial
uncoupling protein 1 (UCP1) to uncouple ATP from the electron transport chain, and use the
energy to combat hypothermia, obesity, and diabetes; brown fat can be activated by either cold
exposure, or β adrenergic signaling (Barbatelli et al., 2010; Bernardis & Bellinger, 1991; GomezHernandez, Beneit, Diaz-Castroverde, et al., 2016).
Brown and white fat come from two different cellular lineages. Brown fat comes from a
myogenic factor 5 (Myf5+)/ paired box protein (Pax7+) cellular lineage; muscle tissue also stems
from this cellular lineage(Christian & Parker, 2010; Garcia-Arcos et al., 2013; GomezHernandez et al., 2012). The PR-domain contain 16 protein (PRDM16) is an important
transcriptional factor for brown adipocytes; in-vitro studies have shown it can be a determining
factor in the muscle/brown adipose Myf5+ lineage. If PRDM16 is knocked out, then the cells
become muscle (Christian & Parker, 2010; Garcia-Arcos et al., 2013; Gomez-Hernandez et al.,
2012). While the cellular lineages may be different, the core elements of the adipogenic cascade
are shared by all types of fat. The master regulator of fat cell formation is peroxisome
proliferator-activated receptor gamma (PPARγ) (Srikanthan, Shapiro, et al., 2016). CCAAT
Enhancer Binding Protein alpha (CEBPα) is an important transcriptional cofactor and is locked
in a differentiation loop with PPARγ (as one increases so does the other) (Carmona et al., 2005;
Kajimura et al., 2008; Kozak, 2011). To a point, this cascade is the same for both white and
brown fat. Early B Cell Factor 2 (ebf2) is an important protein that recruits PPARγ to sites that
will be brown fat (Elattar & Satyanarayana, 2015; J. Wang & Tontonoz, 2017).
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While the differentiation cascade is similar, the function of brown fat is significantly
different from white fat. Brown fat consists of brown adipocytes with a polygonal shape,
centered oval nucleus, and a large cytoplasm that contains multiple small lipid droplets (GomezHernandez, Beneit, Diaz-Castroverde, et al., 2016; Gomez-Hernandez, Beneit, Escribano, et al.,
2016). It has a large number of mitochondria, is highly vascularized, and is responsible for the
secretion of a different set of adipokines (sometimes known as “batokines”)(Gomez-Hernandez,
Beneit, Diaz-Castroverde, et al., 2016). Brown adipose tissue doesn’t accumulate macrophages,
due to the larger number of mitochondria present; the macrophages that brown adipose acquires
have a different expression profile compared to white adipose tissue macrophages (GomezHernandez, Beneit, Diaz-Castroverde, et al., 2016; Greenberg & Obin, 2006; Wellen &
Hotamisligil, 2003). Activation of brown adipose tissue has been implicated as a protective
effect against obesity and reduces adiposity (Gil et al., 2011; Gomez-Hernandez, Beneit, DiazCastroverde, et al., 2016).
Brown adipocytes can sometimes be found inside white adipose; they do not come from
the same Myf5 lineage as brown cells, and are known as “beige” adipocytes(Gomez-Hernandez,
Beneit, Diaz-Castroverde, et al., 2016). Beige fat is a unique type of fat that is genetically
distinct. Beige cells seem to be capable of expressing abundant UCP1. They express the ability
to switch between an energy storing and energy releasing phenotype, depending on
environmental cues/conditions, and have a high respiratory capacity (Ahima, 2016; Becerril et
al., 2013; Chondronikola & Sidossis, 2019). They have characteristics of both white and brown
fat; while white fat cannot be completely changed to brown fat, under certain conditions, it can
gain a beige phenotype or undergo what is called “beiging” of fat (Cohen & Spiegelman, 2015;
Dempersmier & Sul, 2015). When unstimulated, these beige cells have very low basal UCP1
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expression, similar to white adipose; but once stimulated, these cells have a thermogenic profile
similar to brown fat suggesting that the cells are bifunctional, suited for energy storage in the
absence of thermogenic stimuli but fully capable of turning on energy releasing mechanisms
when necessary (Harms & Seale, 2013). These cells have an overlapping but distinct gene
pattern compared to classical brown fat (Carobbio, Guenantin, Samuelson, Bahri, & Vidal-Puig,
2019; Cohen & Spiegelman, 2015). Another feature of beige fat is that it has a higher proportion
of M2 macrophages compared to M1 and an anti-inflammatory cytokine profile, indicating a lean
towards a healthier metabolic phenotype(Harms & Seale, 2013).
Beige cells are highly responsive to the polypeptide hormone irisin (Bostrom et al., 2012;
M. V. Wu, Bikopoulos, Hung, & Ceddia, 2014). Irisin is released during exercise and secreted by
skeletal muscle; it has been shown to induce browning of subcutaneous adipose tissue(GomezHernandez, Beneit, Diaz-Castroverde, et al., 2016). Irisin has little effect on brown fat itself,
suggesting that the responsiveness to irisin may be a selective feature of beige cells localized in
subcutaneous white adipose tissue(Gil et al., 2011; Gomez-Hernandez, Beneit, Diaz-Castroverde,
et al., 2016).
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Figure 5. White Adipose vs Brown Adipose vs Beige Adipose.
White fat cells are the most common fat cell; they are used to store fat and are found
subcutaneously and surrounding organs in the abdomen. Brown fat converts chemical
energy to heat to protect against certain stimuli. Beige fat is a hybrid type of fat that
behaves similarly to both types of fat.

Connections between Na/K-ATPase Oxidant Amplification Loop and Obesity: Current
Research
ROS has been implicated in both abnormal Na/K-ATPase signaling and the exacerbation
of obesity; simply put, the pathological natures of dysregulated Na/K-ATPase signaling and
dysfunctional adiposity are linked by ROS.
ROS has been established as one of the chemical classes that can act as a ligand for the
Na/K-ATPase; it is a chemical modifier that can either reversibly or irreversibly change the
conformation of the Na/K-ATPase(Z. Xie, 2003). Binding of ouabain to the Na/K-ATPase
results in activation of the Ras-Raf-MEK-ERK pathway, which subsequently leads to activation
of MAPK and an increase in intracellular Ca2+ concentrations; this is responsible for the opening
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of mitochondrial ATP-sensitive K+ channels and increased mitochondrial ROS
production(Greenberg & Obin, 2006; Srikanthan, Shapiro, et al., 2016; Z. Xie, 2003).
Increased ROS production from obesity (a disease of chronic inflammation) can oxidize
the Na/K-ATPase, which inhibits its activity and promotes susceptibility to degradation by
proteosomal and endosomal/lysosomal proteolytic pathways; this oxidized modification is
normally reversible, but increased presence of ROS speeds it up, leading to a decrease in
functional Na/K-ATPase α1, and a decrease in the ability of the cell to “rescue” recycled Na/KATPase(Blanco, 2005; J. Liu, Kennedy, Yan, & Shapiro, 2012; Srikanthan, Shapiro, et al., 2016;
Z. Xie, 2003; Yan et al., 2013).
It has been discussed above that ROS production increases in parallel with fat
accumulation in obesity; macrophages infiltrate adipose tissue and increase inflammatory
cytokines and augment ROS production, which in turn upregulates expression of
proinflammatory cytokines and stimulates more ROS production(Srikanthan, Shapiro, et al.,
2016; Z. Xie, 2003). Obesity tends to decrease expression and activity of cytoprotective systems
including heme oxygenase 1 (HO-1) and adiponectin while increasing inflammation (Cao et al.,
2012; Cao, Sodhi, Inoue, et al., 2011). Hypertriglyceridemia and hyperglycemia, both associated
with increased adiposity, have been shown to increase plasma FFA into circulation, which can
lead to increased ROS generation and oxidative stress (Sodhi et al., 2017). The imbalance of proand anti-oxidants that comes from an obese phenotype results in systemic oxidative stress, which
maintains the phenotype and sustains oxidation of the Na/K-ATPase, leaving it in a constant E2
conformation. This prevents the Na/K-ATPase signaling cascade from turning off, and leads to
abnormal signaling phenomena, increased c-Src activation, further increased ROS expression,
and exacerbation of conditions related to redox imbalance (i.e. obesity, dyslipidemia, diabetes,
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and atherosclerosis) (Bartlett, Miller, Thiesfeldt, Lakhani, Khanal, et al., 2018; Sodhi et al.,
2017; Srikanthan, Shapiro, et al., 2016; Z. Xie, 2003; Yan et al., 2013). This points to the
interaction between ROS, obesity, and the Na/K-ATPase, indicating that the Na/K-ATPase is a
feed forward amplification loop for oxidants; it acts as a receptor for ROS, inducing
conformational changes in the α1 subunit and an impaired signaling profile that intensifies the
development of and pathogenesis of obesity (J. Liu et al., 2016; Sodhi et al., 2015; Sodhi et al.,
2018; Sodhi et al., 2017).

Figure 6. Proposed ROS Mediated Interaction Between Na/K-ATPase and Obesity.
There is a complex interaction between ROS, obesity, and the Na/K-ATPase, which
indicates that the Na/K-ATPase is a feed forward amplification loop for oxidants; it acts as a
receptor for ROS, inducing conformational changes in the α1 subunit and an impaired
signaling profile that intensifies the development of and pathogenesis of obesity.
When administered systemically, pNaKtide was shown to decrease adiposity, improve
glucose tolerance, decrease incidence of NASH, and decrease the inflammatory profile of mice
given a western diet (WD)(Sodhi et al., 2015). Dysfunctional adipogenesis is a hallmark of
obesity and is characterized by altered endocrine function of adipose tissue; adipose tissue
regulates energy metabolism via the secretion of adipokines. Dysregulated production of these
adipokines has harmful effects including increased obesity and an impaired metabolic profile
(Sodhi et al., 2015; Srikanthan, Shapiro, et al., 2016). Given this, we wanted to examine whether
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adipocyte-specific expression of NaKtide could have a similar ameliorative effect as when
pNaKtide is administered systemically. This tissue specific administration was done via a
lentiviral mechanism which allowed NaKtide to permeate the cell. We believe that using a
lentiviral vector with NaKtide can both avoid the potentially toxic effect, and also prevent the
risk of exocytosis of NaKtide to neighboring tissues.
Lentivirus is a complex retrovirus that has been rendered replication incompetent to
prevent random mutations; lentivirus (with a specific gene/drug attached) infects the host cell
and integrates its own genome into the host cell’s DNA. Each new cell has expression of the
drug or gene, but no new virus is formed (Figure 7) (Cao et al., 2012; Cao, Sodhi, Inoue, et al.,
2011; Z. J. Liu et al., 2011; Manickam et al., 2018).

Figure 7. Lentiviral infection of host cell.
Lentivirus (with a specific gene or drug product) infects the host cell. It integrates its
genome (and thus the gene or drug) into the host cell’s DNA, so that each new cell will
have expression of the gene or drug but lentivirus has been rendered replication
incompetent. Each new cell will have expression of the drug, but no new virus is being
made.
Over the last decade, lentivirus has emerged as a promising gene therapy. There is little
to no risk of infection in humans. It is stable with low mutation rates and, most importantly, it
provides the ability to study the effect of a drug or gene product on a specific tissue based on the
specificity of the promoter (Cao et al., 2012; Cao, Sodhi, Inoue, et al., 2011; Gao et al., 2018). In
the case of this work, an adiponectin promoter was used to drive the lentivirus with NaKtide to
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adipose tissue. There are other viral transfection therapies. Adenovirus, influenza virus, and
cytomegalovirus are three examples. There are individual risks associated with each of these
viruses, but the overall problem is that it is difficult to knock out replication abilities in these
viruses and thus humans are extremely susceptible to infection by these viruses(Bian, Bai, Zhao,
Zhang, & Liu, 2013; Cao, Sodhi, Inoue, et al., 2011).
Previous data, and the data herein, suggest that adipocyte derived cytokines play an
essential role in the development of obesity induced by a WD, and that targeting the adipocyte
Na/K-ATPase may serve as an effective therapeutic strategy. Specific expression of NaKtide in
adipocytes via lentiviral vectors modulates the adipocyte’s redox state and ameliorates systemic
oxidative stress, therefore preventing development of pathological adipocyte phenotype.
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Introduction
Hypertension is defined as elevated blood pressure—typically a systolic blood pressure
of ≥140 mmHg or a diastolic pressure ≥90 mmHg (or both) in a relaxed state (Abraham, Asija,
Drummond, & Peterson, 2007; Adedayo et al., 2014; Canning, Brown, Jamnik, & Kuk, 2014).
Currently, 29% (or 70 million) of Americans have been diagnosed with hypertension (Cohen &
Spiegelman, 2015; Yang, Bi, & Kuang, 2014). There are several stages of hypertension, as well
as salt sensitive and salt resistant types of hypertension (J. Chen et al., 2009). Hypertension may
complicate and/or worsen other diseases such as diabetes, cardiovascular disease, chronic kidney
disease, and obesity (Adedayo et al., 2014; Albert, Aguglia, Chiarle, Bogetto, & Maina, 2013; T.
M. Brown et al., 2008; Herath Bandara & Brown, 2013). Obesity itself has reached pandemic
proportions; according to the World Health Organization (WHO), over 500 million adults (1014% of world population) were obese in 2008, and this number keeps increasing (Adedayo et al.,
2014; T. M. Brown et al., 2008; Herath Bandara & Brown, 2013). As of 2014, this number has
jumped to 600 million. There is an association between hypertension and obesity, but the
mechanism(s) by which obesity predisposes to hypertension in humans has not be clearly
established. In this review, we will explore some aspects of this important relationship.
The three known types of adipose tissue
Currently there are three known types of adipose tissue, each with its own specific
characteristics: white, brown, and a mixture type, known as beige (or “brite”). The main purpose
of adipose, regardless of the type, is to store excess energy that can be released as needed. The
way the energy is stored varies between types. White adipose is the type one would think about
when thinking about typical obesity. White adipocytes (WAT) are characterized by a spherical
shape, a large lipid droplet that takes up 90 % of the volume of the cell, very few mitochondria,
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and a flattened peripheral nucleus (Alvarez et al., 1995; Bonet, Serra, Matamala, Garcia-Palmer,
& Palou, 1995; Brestoff et al., 2015; Farooqi & O'Rahilly, 2009; Fonseca-Alaniz, Takada,
Alonso-Vale, & Lima, 2007; Gil et al., 2011). WAT can release triglycerides during a time of
energy crisis in the body. WAT can be found virtually anywhere on the body, but are mainly
located in subcutaneous abdomen, viscera, retroperitoneal, inguinal, and gonadal areas (Adams
et al., 2008; Alvarez et al., 1995; Burgess et al., 2010; Cinti et al., 1997; Cohen, Ntambi, &
Friedman, 2003). White adipocyte cells are known to secrete several kinds of proteins, such as
inflammatory factors and the protein leptin (Abraham et al., 2014; Almabrouk, Ewart, Salt, &
Kennedy, 2014; Bianco, Kieffer, & Silva, 1992; Cinti et al., 1997; Cohen & Friedman, 2004;
Cohen et al., 2003).
Leptin is known as the satiety protein; when released, it inhibits feelings of hunger
(Farooqi & O'Rahilly, 2009; Fonseca-Alaniz, Takada, et al., 2007). The antagonist of leptin is
ghrelin; this is thought to be one of the hunger hormones (Cinti et al., 1997; Cohen & Friedman,
2004; Cohen et al., 2003; Farooqi & O'Rahilly, 2009). It has clearly been shown by Friedman
and colleagues that patients with an inability to produce leptin develop profound hyperphagia
and obesity (D. J. Friedman et al., 2009; J. Friedman, 2014; J. M. Friedman, 2011; Sennello et
al., 2005). However, in most obese subjects, leptin levels are high (J. Friedman, 2014; J. M.
Friedman, 2011). In these subjects, it is thought that as leptin levels are chronically elevated,
responses to leptin are diminished(J. M. Friedman, 2011). Despite the high amount of energy
already stored, the body ignores satiety signals and thinks it requires more energy to store; this
higher level of leptin is consistent with a higher amount of adipocytes which are believed to be
the primary source of leptin (J. Friedman, 2014; J. M. Friedman, 2011; Simonds et al., 2014; Y.
T. Zhou et al., 1997). This hormone and protein releasing function therefore places white adipose
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tissue as an endocrine organ (Fonseca-Alaniz, Takada, et al., 2007; Villacorta & Chang, 2015;
M. V. Wu et al., 2014).
In addition to leptin, adipocytes also release other hormones and peptides, including
TNFα and IL-6(Sodhi et al., 2015; Sodhi et al., 2014; Wong, Ward, Fong, Yap, & Brown, 2015;
Yoda et al., 2015). These are inflammatory cytokines, and the increased levels are indicative of
inflammation in the body (Sodhi et al., 2014; Wong et al., 2015; Yoda et al., 2015). Whether
this inflammation leads to increased reactive oxygen species (ROS) production creating
oxidative stress or oxidative stress from signaling leads to inflammation is currently unclear.
Brown adipocytes (BAT) are a bit different from white adipocytes; they are polygonal in
shape, contain fewer and smaller lipid molecules, have abundant mitochondria, and a central
round nuclei (Alvarez et al., 2000; Alvarez et al., 1995; Bonet et al., 1995). Brown adipocytes
are mainly found in the subscapular region of rodents and human infants (Alvarez et al., 1995;
Martin et al., 1999) . Whereas white adipocytes use lipids to store energy, brown adipocytes
store energy in the form of fat and break them down to produce heat in a process known as nonshivering thermogenesis (Klingenspor, 2003; Klitsch & Siemen, 1991; Strack, Bradbury, &
Dallman, 1995). Thermogenesis is the production of heat in an organism; non-shivering
thermogenesis occurs in the brown adipose tissue because of the presence of thermogenin
(Herron et al., 1990; Palou, Pico, Bonet, & Oliver, 1998; Puigserver, Vazquez, Bonet, Pico, &
Palou, 1996; Rehnmark, Nechad, Herron, Cannon, & Nedergaard, 1990). Thermogenin (also
known as uncoupling protein 1) allows the uncoupling of protons moving down their gradient
from ATP synthesis; this energy is then dissipated as heat (Herron et al., 1990; Palou et al.,
1998). Free fatty acids from the brown adipose tissue remove any proteins that could inhibit
thermogenin (Puigserver et al., 1996; Rehnmark et al., 1990). Thermogenin then causes an influx
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of H+ into the mitochondrial matrix, bypassing the ATP synthase normally used to make ATP
(C. Z. Wang, Wei, Guan, & Xue, 2014; S. Wang et al., 2015; Xue et al., 2015; J. Zhou et al.,
2015; Zietak & Kozak, 2015). This uncouples oxidative phosphorylation, and the energy
normally used to convert ADP to ATP is release as heat (Sacks et al., 2009; Xing, Yang, &
Wang, 2015; Yan et al., 2013; J. Zhou et al., 2015). Interestingly, thermogenesis can also be
produced ion pump leakage (Bednar & Soukup, 2003; Kopecky et al., 1990; Yan et al., 2013). It
is thought that a leaky ion pump in mitochondria releases H+ ions; the intensity of heat is
proportional to the amount of H+ released during this process (Palou et al., 1998; Rehnmark et
al., 1990). The ability of brown adipocytes to turn excess energy into heat is a property the white
adipocytes lack (Sacks et al., 2013; Sharp et al., 2012; Vargas et al., 2016; Yang et al., 2014).
Circulating factors, such as irisin, FGF-21, and natriuretic peptides play a role in regulating
brown adipocytes. It is thought that these factors can encourage proliferation of brown
adipocytes, and increase the amount of present beige adipocytes (Sharma et al., 2014; Sharp et
al., 2012; Vargas et al., 2016).
Beige adipocytes are a combination of brown and white adipocytes (Yang et al., 2014).
Beige adipocytes are born through a browning process; white adipocytes become more like
brown adipocytes, the one large lipid droplet becomes many, and uncoupling protein 1 becomes
expressed, and thermogenic activity increases (Cohen & Spiegelman, 2015; Sharma et al., 2014;
Sharp et al., 2012). All three types of adipocyte cells, along with muscle cells, come from the
same precursor cell—a mesenchymal stem cell (Cohen & Spiegelman, 2015; Yang et al., 2014).
The expression of different genes at different points during the life cycle of these cells
determines their fate (Cohen & Spiegelman, 2015; Yang et al., 2014), see Figure 8. The
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potential for obese adults to spontaneously form beige adipocytes from their white adipocytes is
unclear, but it brings to mind the possibility that such a phenomenon is possible.

Figure 8. Schematic demonstrating links between three basic type of adipocytes and
muscle.
All cells come from the same common cell, mesenchymal stem cell. Presence or absence of
certain factors during development, such as Myf5, Pax 3 and 7, PDGFRa and myogenin can
affect the final product of the cell. Myf5: Myogenic factor 5; Pax 7: Paired box protein 7;
Pax 3: Paired box protein 3; PDGFRa: Platelet-derived growth factor receptor, alpha
polypeptide.
The relationship between hypertension and obesity
Obesity can increase the susceptibility to metabolic syndromes, cardiovascular diseases,
Type 2 diabetes, cancer, and hypertension. Although some patients with hypertension are not
obese, and vice versa, there is a strong correlation across populations(P.T. Shah, Shapiro, Khitan,
Santhanam, & Shapiro, 2016). The interactions between obesity, salt sensitivity and hypertension
are shown schematically in Figure 9. When blood pressures reach the hypertensive range, there is
almost always small vessel disease of the arterioles, or arteriolosclerosis, as well as kidney

30

damage (Sasaki, Uchida, Niiyama, Yoshida, & Saito, 1998; Sharma et al., 2014; Watanabe et al.,
2013). This strongly suggests that there are both vascular and renal components to the disease (J.
E. Hall et al., 2012). Hypertension has genetic and environmental factors in addition to those
associated with obesity (Shungin et al., 2015; Simonds et al., 2014; Yang et al., 2014; S. Zhang
et al., 2016). Salt sensitive hypertension refers to an increase in blood pressure related to an
increase in salt (specifically sodium) intake (J. Chen et al., 2009; Gilibert et al., 2008; Mori et al.,
1999). Some workers in this field believe that all hypertension reflects either excessive sodium
intake or some form of renal salt sensitivity, but this is admittedly still controversial (Fedorova,
Shapiro, & Bagrov, 2010; J. E. Hall et al., 2012; J. E. Hall, Guyton, & Brands, 1996; J. X. Xie,
Shapiro, & Shapiro, 2014).

Figure 9. Schematic demonstrating potential relationship between obesity and
hypertension.
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Present theories linking obesity to hypertension
Obesity appears to be associated with or complicated by “increased sympathetic nervous
system (SNS) activity, activation of the renin-angiotensin aldosterone system (RAAS), and
physical compression of the kidneys by extra-renal fat and by increased intrarenal extracellular
matrix”(J. E. Hall et al., 2010; J. E. Hall, do Carmo, da Silva, Wang, & Hall, 2015; J. E. Hall,
Granger, Reckelhoff, & Sandberg, 2008). This physical compression can directly activate the
RAAS which, in turn, leads to increased SNS outflow as well as increased circulating
concentrations of angiotensin II, a well-known vasoconstrictor and aldosterone, an antinatriuretic hormone. The net effect is sodium retention and increased blood pressure (J. E. Hall et
al., 2012; J. E. Hall et al., 2008; J. E. Hall, Jones, et al., 2003; J. E. Hall, Kuo, et al., 2003) .
Leptin levels, as discussed above, appear to be increased in obese patients. This hormone
through several biochemical mechanisms, affects appetite as well as SNS outflow, and can cause
increases in blood pressure (J. E. Hall et al., 2010; J. E. Hall, Jones, et al., 2003). The duration of
obesity also plays a role; the longer one is obese, the more renal damage occurs which further
impairs pressure natriuresis, exacerbating hypertension (da Silva, do Carmo, & Hall, 2013; J. E.
Hall et al., 2010; J. E. Hall et al., 2015; J. E. Hall et al., 2012; M. E. Hall et al., 2014).
Another potentially contributing factor is Obstructive Sleep Apnea (OSA), which is more
than just another co-morbidity of obesity. OSA is much more common in people who are
overweight or obese (Abraham et al., 2007; Adedayo et al., 2014). OSA occurs when the airway
becomes blocked or constricted and can cause snoring, and lapses in breathing that are common
to sleep apnea (Adedayo et al., 2014; Al-Jehani, Hall, & Maleki, 2013; Dharia, Unruh, & Brown,
2015). Untreated sleep apnea can lead to increases in blood pressure, obesity, heart attack risk,
and diabetes, among other problems (Adedayo et al., 2014; Albert et al., 2013; Allison, Gertsch,
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Mahan, Sheean, & Brown, 2014; Alonso-Galicia, Brands, Zappe, & Hall, 1996; Fonseca-Alaniz,
Brito, et al., 2007; J. E. Hall, Kuo, et al., 2003). In addition to increasing the risk for
hypertension, OSA can lead to other problems. Hypoxia, or lack of oxygen that occurs when
breathing is stopped or obstructed, is also a risk factor for generating ROS and increasing oxidant
stress and SNS activity (Abraham et al., 2007; Adedayo et al., 2014; Al-Jehani et al., 2013;
Fonseca-Alaniz, Brito, et al., 2007).
Recent work suggests that the adipocyte itself could play an important role in
hypertension. Research has shown that high dietary sodium can increase the white adipocyte
mass as well as leptin levels in rats (Fonseca-Alaniz, Brito, et al., 2007), and blood pressure was
significantly increased as well. The increase in adipocyte mass has a cascading effect; the mass
increases, the release of additional adipokines occurs, and these lead to an increase in
inflammation. This inflammation causes further exacerbation of disordered metabolism and
insulin resistance (Alon & Friedman, 2006; Enzi et al., 2015; Fonseca-Alaniz, Brito, et al., 2007;
Gutierrez, Puglisi, & Hasty, 2009). These interactions are shown schematically in Figure 10 and
Figure 11.
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Figure 10. Visual representation of factors contributing to the complex pathophysiology
linking adipocyte biology and hypertension
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Figure 11. Small adipocytes release anti-inflammatory agents such as adiponectin,
interleukin 10, and interleukin 1 receptor antagonist.
Hypertrophy of small adipocytes into large adipocytes changes the biochemical release
products, into inflammatory markers [interleukin-6 (IL-6), tumor necrosis factor alpha
(TNFα), and monocyte chemotactic protein 1 (MCP-1)] and other chemicals such as leptin and
angiotensin II that contribute to the disease. Increased activation of the sympathetic nervous
system also contributes. IL-10: Interleukin-10; IL-1R: Interleukin 1 receptor; Myf5: Myogenic
factor 5; Pax 7: Paired box protein 7; Pax 3: Paired box protein 3; ROS: Reactive oxygen
species.

Current treatments of obesity and their effects on hypertension
Currently, there are several treatment methods to deal with obesity, and as it is so closely
related with hypertension, treatments for the two can often overlap (Blood Pressure Lowering
Treatment Trialists et al., 2015; G. Bray, 1998; A. D. Brown, Barton, & Lambert, 2009). The
treatments can be broken up into several categories; lifestyle changes (including nutritional
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changes and exercise addition), drug therapy, and surgical methods(Alemany, Remesar, &
Fernandez-Lopez, 2003). It has been shown that a reduction in a patient’s weight by 5-10% is
enough to reduce their risk of cardiovascular complications, including hypertension (Alemany et
al., 2003; Atkinson, Blank, Loper, Schumacher, & Lutes, 1995; Barja-Fernandez, Leis,
Casanueva, & Seoane, 2014). When looking at the drug treatment route, it is important to
consider however that some drugs are not recommended for patients who have pre-existing
conditions, such as hypertension or diabetes. Sibutramine, for example, has been associated with
small increases in blood pressure and heart rate, and is not recommended for patients suffering
from hypertension (Alemany et al., 2003; Ioannides-Demos, Proietto, Tonkin, & McNeil, 2006).
Some drugs that are used to treat hypertension can be used as a weight loss agent, such as the
drug orlistat (Alemany et al., 2003; Charakida, Tousoulis, & Finer, 2013). These drugs can work
on multiple levels; some are known as feeder modulators, and change the way the patient
receives signals that the body needs food (Alemany et al., 2003; G. A. Bray, 1999). Some effect
the formation of agents such as angiotensin II and nitric oxide synthase (Alemany et al., 2003;
Charakida & Finer, 2012; Cheung, 2011). Still others work at the molecular level and effect the
afferent signaling that can lead to obesity (Alemany et al., 2003; Charakida & Finer, 2012).
Serotonin drugs have been found to be an effective treatment of obesity, but the downside is they
can cause an increased risk of primary hypertension because of their effects on vascular smooth
muscle(Halford, Harrold, Lawton, & Blundell, 2005). If we look at surgical approaches, the
benefits of surgery on hypertension itself and the abnormal hormonal milieu appear to be huge,
at least over the first year or so (Ruano et al., 2005).
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Redox reactions and their relation to obesity and hypertension
In addition to salt intake and obesity, nitrous oxide synthase and heme oxygenase both
play a role in the cause and treatment of hypertension (De Simone et al., 2015; Ishima et al.,
2015; X. Zhou et al., 2010). Obesity leads to an imbalance in the circulating level of nitic oxide
(NO); this is due to increased oxidative stress and decreased NO production (Ishima et al., 2015;
Merial, Bouloumie, Trocheris, Lafontan, & Galitzky, 2000). Decreasing the availability of the
NO can predispose an individual to hypertension (De Simone et al., 2015; Ishima et al., 2015; X.
Zhou et al., 2010). NO contributes to vasodilation, which is the relaxation of the vasculature (De
Simone et al., 2015; Ishima et al., 2015; X. Zhou et al., 2010). If there is less NO present
(because of a decrease in NO synthase), vasoconstriction can occur, which can exacerbate the
damage of increased pressure from the other factors related to hypertension (De Simone et al.,
2015; Ishima et al., 2015; X. Zhou et al., 2010). Human adipose tissue expresses
angiotensinogen, angiotensin-converting enzyme (ACE) as well as AT1 (angiotensin type 1), and
AT2 (angiotensin type 2) receptors (Hilzendeger et al., 2012; Peterson, Frishman, & Abraham,
2009; Westphal et al., 2008). The role of angiostatin is not well known, but it has some kind of
redox purpose; it appears to involve inhibition of endothelial cell migration, proliferation and
induction of apoptosis (De Simone et al., 2015; Ishima et al., 2015; X. Zhou et al., 2010). There
is a link between NO synthase dysfunction and the ACE enzyme in the obese population (De
Simone et al., 2015; Ishima et al., 2015; X. Zhou et al., 2010). Excessive NO formation by the
inducible member of the nitric oxide synthase (NOS) family (iNOS or Nos2) has been shown to
cause nonspecific tissue damage; it is thought to be involved in the pathogenesis of inflammatory
and autoimmune diseases(Marcano et al., 2007; Rodella et al., 2008; Zaitone et al., 2015). By
inhibiting this inducible factor, obesity still occurs but the pathologies associated are reduced
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(Rodella et al., 2008). A similar study showed that even though mice protected from pathologies
associated with INOS inhibition, they are still subjected to increased blood pressure and
increased ROS (Y. Chen, Liu, et al., 2015; Klein, Fasshauer, Benito, & Kahn, 2000). iNOS is
associated with increased inflammatory responses, which is related to the cascade of responses
associated with obesity and hypertension(Cao, Sodhi, Puri, et al., 2011; Sodhi et al., 2012; Sodhi
et al., 2014; Wong et al., 2015). It is known that increased NO can induce cellular stress, which
can exacerbate the current problems present.
Similarly to NO synthase, heme oxygenase (HO) has a role in amelioration of hypertension
(Abraham et al., 2007; Ishima et al., 2015; Peterson et al., 2009; Rodella et al., 2008; Vanella et
al., 2013). An increase in HO expression can cause reductions in reactive oxygen species, or
ROS. Increases in ROS, also called oxidant stress, are believed to be important in the progression
of hypertension and associated cardiovascular diseases. The isoform HO-1 is the inducible form
of heme oxygenase, and when induced it can cause a decrease in weight, and therefore a decrease
in obesity (Kamble, Litvinov, Aluganti Narasimhulu, Jiang, & Parthasarathy, 2015; Vanella et
al., 2010; Vanella et al., 2013). HO does this by changing the phenotype of the adipocyte
(Nicolai et al., 2009; Vanella et al., 2013). HO-1 can interact with NO in several ways, one of
which is through AngII (Valladares, Roncero, Benito, & Porras, 2001; Westenbrink et al., 2015;
X. Zhou et al., 2010). Increased AngII production causes an increase in ROS, which may inhibit
the action of NO (Ishima et al., 2015; P. Wang et al., 2014). This can also increase salt
reabsorption. When HO-1 expression is increased, the increases in AngII levels are attenuated;
this decreases AngII’s downstream signaling effects (Valladares et al., 2001; Westenbrink et al.,
2015; X. Zhou et al., 2010). Induction of HO-1 can also reduce the renal vasculature resistance
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that is increased with AngII level increases (Valladares et al., 2001; Westenbrink et al., 2015; X.
Zhou et al., 2010).
Several studies have shown that induction of HO-1 not only decreases weight and
obesity, but it can also prevent the development of hypertension, even if its expression is limited
to adipocytes (Abraham et al., 2007; Cao et al., 2012). It is not clear if blood pressure is lowered
through the indirect effects on the vasculature, kidney, or through the release of other enzymes
and factors. If induction of HO-1 is done at any step in the pathway described above, what are
the specific effects? If induced during any stage of hypertension, will effects still be seen, or does
it need to be induced early in obesity?
Abraham, et. al., look specifically at the role of HO-1 and the effects it can have on
various aspects of obesity. One study specifically examines adipocyte dysfunction; induction of
HO-1 can reverse adipocyte dysfunction and to an extent reverse effects of damage(Khitan,
Harsh, Sodhi, Shapiro, & Abraham, 2014). This lab has also shown significant findings of the
role of HO-1 and the attenuating effects it can have with hypertension (Abraham, 2008;
Abraham et al., 2007; Abraham & Kappas, 2011). We have also looked from the other
perspective, namely ROS generation. We have recently observed that attenuation of ROS
generation with pNaKtide (Z. Li et al., 2009; Z. Li et al., 2011), a peptide designed to ameliorate
the Na/K-ATPase mediated feed forward amplification of ROS (Yan et al., 2013), prevents
phenotypical changes within adipocytes as well as ameliorates diet induced obesity in mice
(Sodhi et al., 2015).
Conclusions and future directions
There is clearly a very strong relationship between obesity and hypertension. While a
plethora of mechanisms potentially link obesity to hypertension, we are left with the provocative
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possibility that adipocyte biology may play an important role in blood pressure regulation, a
topic which to date has not been systematically explored.
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CHAPTER 3
THE NA/K-ATPASE SIGNALING: FROM SPECIFIC LIGANDS TO GENERAL
REACTIVE OXYGEN SPECIES
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Abstract: The signaling function of the Na/K-ATPase has been established for 20 years, and is
widely accepted in the field with many excellent reports and reviews that we did not cite. Even
though there is debate about the underlying mechanism, the signaling function is unquestioned.
This short review looks back at the evolution of Na/K-ATPase signaling, from stimulation by
cardiotonic steroids (also known as digitalis-like substances) as specific ligands to stimulation
by reactive oxygen species (ROS) in general. The interplay of cardiotonic steroids and ROS in
Na/K-ATPase signaling forms a positive-feedback oxidant amplification loop that has
implicated in some pathophysiological conditions.
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Introduction
Since J.C. Skou’s discovery in 1957 (Skou, 1957), the energy-transducing Na/K-ATPase
has been extensively studied for its ion pumping function and later on, its signaling function. The
latter signaling function was first demonstrated about two decades ago, and evolved to a much
bigger signaling network (and has kept evolving) one could not imagine before.
All starts with the possible role of Na/K-ATPase in cardiac hypertrophy. In a classic
view, partially inhibition of Na/K-ATPase ion-exchange activity raises intracellular sodium
concentration ([Na+]i), which in turn, increase intracellular calcium concentration ([Ca2+]i) by
coupling with Na+/Ca2+ exchanger (NCX) to execute inotropic effect. This is the basis of the
treatment of heart failure with digitalis-like drugs. Furthermore, partial inhibition of Na/KATPase not only causes intracellular ionic changes, but also stimulates transcriptional upregulation of several marker genes including Na/K-ATPase itself. However, further studies were
unable to directly link ouabain-mediated gene regulation effects to changes in intracellular [Na+]i
or [K+]i caused by Na/K-ATPase inhibition. In cultured cardiac myocytes, treatment with
nontoxic concentrations of ouabain not only partially inhibited Na/K-ATPase activity and
increased cardiac contractility, but also stimulated cell growth and protein synthesis through
induction of early response proto-oncogenes and activation of transcription factors (L. Huang,
Kometiani, & Xie, 1997; L. Huang, Li, & Xie, 1997; Kometiani et al., 1998; Peng et al., 1996;
Sugden, 1999; Z. Xie & Askari, 2002; Z. Xie et al., 1999). These discrepancies started the search
for mechanism(s) other than ionic changes.
Na/K-ATPase signaling and intracellular ionic concentration
As mentioned above, changes in [Na+]i, [K+]i, and [Ca2+]i were largely attributed to
changes in Na/K-ATPase activity that can be regulated by specific ligands cardiotonic steroids.
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Interestingly, Na/K-ATPase activity can also be regulated by changes in cellular redox status,
induced by either cardiotonic steroids or other factors. In cardiac myocytes, inhibition of Na/KATPase ion exchange function leads to decrease of [K+]i and increase of [Na+]i. By coupling to
NCX, this increase in [Na+]i elevates intracellular [Ca2+]i, which is the leading force of the
positive inotropic action induced by digitalis drugs for treatment of heart failure (Barry, Hasin, &
Smith, 1985; Reuter et al., 2005). To address the role of these ionic changes, ouabain-induced
ROS generation (an essential second messenger) and increase in [Ca2+]i (a shared secondary
messenger) were manipulated to investigate the possible interplay. Ouabain-induced ROS
generation was compared in cardiac myocytes cultured in Ca2+-free medium (with 0.1 mM
EGTA) and Ca2+-containing medium, respectively. In neonatal cardiac myocytes cultured in
Ca2+-free medium, in which ouabain did not change [Ca2+]i, ouabain was still able to stimulate
ROS generation as shown in myocytes cultured in Ca2+-containing medium, but unable to
stimulate increase of [Ca2+]i and contractility in neonatal cardiac myocytes (J. Liu et al., 2000).
Furthermore, in neonatal cardiac myocytes cultured in Ca2+ free medium with high Na+
(150mM), monensin, a Na+-specific ionophore capable of equilibrating Na+ concentration across
cell membrane, failed to increase ROS generation. Interestingly, inhibition of c-Src or Ras, as
well as antioxidants can block ouabain-stimulated ROS generation, but not ouabain-induced
increases in [Ca2+]i (Tian, Gong, & Xie, 2001; Tian, Liu, Garlid, Shapiro, & Xie, 2003; Z. Xie et
al., 1999). These observations suggested that increases in [Ca2+]i is necessary in ouabain-induced
increases in cardiomyocytes contractility and gene regulatory effects, but is not necessary in
ouabain-stimulated ROS generation. Moreover, Ouabain-stimulated Na/K-ATPase signaling also
increases generation of ROS which functions as a second messenger. Pretreatment with
antioxidants, such as N-acetylcysteine (NAC) or vitamin E, neutralized the increases of ROS,

43

and therefore, prevented ouabain-stimulated activation of NF-κB and protein synthesis (J. Liu et
al., 2000; Z. Xie et al., 1999). Ouabain-induced increases in ROS production involves opening of
mitochondrial ATP-sensitive K+ channels (mitoKATP) (J. Liu et al., 2000; Tian et al., 2003).
Notably, ouabain-induced increases in [Ca2+]i is also involved in ouabain-stimulated
Na/K-ATPase signaling. In renal epithelial cells, low doses of ouabain (only inhibit Na/KATPase activity partially) functioned as an inducer/trigger of regular, low frequency [Ca2+]i
oscillations is involved the Na/K-ATPase/ inositol 1,4,5-trisphosphate receptors (IP3Rs)
signaling micro-domain that leads to NF-кB activation (Aizman et al., 2001; Miyakawa-Naito et
al., 2003). This phenomena does not depend on partial inhibition of Na/K-ATPase using low
extracellular K+ and depolarization of cells, but is achieved by ouabain-stimulated activation of
tyrosine kinase c-Src and phospholipase C–γ (PLC-γ ), which transmitted the signal to
IP3Rs (Ying Chen et al., 2008; Yuan et al., 2005). Depletion of intracellular endoplasmic
reticulum (ER) Ca2+ by sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor, as well as
blockage of store-operated calcium-mediated cytosolic Ca2+ influx and inhibition of IP3Rsinduced Ca2+ release abolished ouabain-induced Ca2+ oscillations (Miyakawa-Naito et al., 2003).
Truncation of 32 amino acids from the α1 NH2 terminus results in a functional enzyme but
abolishes ouabain-induced Ca2+ oscillations, indicating that the cytoplasmic α1 NH2 terminus
plays a central role in ouabain-induced Ca2+ oscillations (Miyakawa-Naito et al., 2003). The data
from this study also indicates that increased [Na+]i is not the main cause of ouabain-induced Ca2+
oscillations, rather the release of α1 NH2 terminus during Na/K-ATPase E1 to E2 conformational
change (ouabain binding favors E2 conformation) serves as a mean of α1/IP3Rs complex
formation. This was further confirmed that the α1 NH2 terminus binds directly, through motif
LKK, with the IP3R NH2 terminus (Songbai Zhang et al., 2006). On the other hand, ouabain
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stimulated the formation of a functional Ca2+-signaling complex including the Na/K-ATPase
α1/c-Src/PLC-γ/IP3R in LLC-PK1 cells, and knock-down of the Na/K-ATPase α1 redistributed
IP3R (Ying Chen et al., 2008). Overexpression of the α1 NH2 terminus (amino acids 1-160) not
only disrupted the interaction of the Na/K-ATPase α1 and IP3R, but it also functioned as a
negative regulator of ATP-induced ER Ca2+ release (Ying Chen et al., 2008). The p42/44
MAPK–mediated activation of Ca2+ channels partially contributes to ouabain-induced regulation
of [Ca2+ ]i (Fitzgerald, 2000; Marban & Tsien, 1982).
Because the effects of ouabain on c-Src are independent of changes in intracellular ion
concentrations (Aydemir-Koksoy, Abramowitz, & Allen, 2001; Haas et al., 2000; Haas, Wang,
Tian, & Xie, 2002; J. Liu et al., 2000) , it seems that ouabain-induced inhibition of Na/K-ATPase
enzymatic activity (ion exchange) and ouabain-induced c-Src-dependent signaling are, at least
partially, two separated regulatory events under these experimental conditions. In addition to
ouabain, changes in intracellular Na+ or extracellular K+ affect not only the enzyme
conformation, but also change other ion transporter–related activities. For example, lowering of
extracellular K+ activates protein kinases and raises intracellular Ca2+ in cardiac myocytes (Haas
et al., 2000) , but it differs from the effects of ouabain on smooth muscle and kidney epithelial
cells (Aizman et al., 2001; Aydemir-Koksoy et al., 2001) . Large bulk changes in [Na+]i or
[K+]i that are not induced by ouabain-Na/K‐ATPase axis also affect other intracellular signal
pathways (Kuroki, Minden, Sanchez, & Wattenberg, 1997; S. Li & Wattenberg, 1998; Pressley,
1992). For example, in cultured porcine aortic endothelial cells, ouabain-mediated complete
inhibition of Na/K-ATPase causes cell necrosis that is independent of ouabain-mediated ion
fluxes and change of [Na+]i/[K+]i ratio, but K+-free ([K+]0=0) medium-caused inhibition of Na/KATPase, which elevates [Na+]i, does not induce necrosis but protects against apoptosis (Orlov et
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al., 2004). The anti-apoptosis effect is regulated by a [Na+]i-mediated, Ca2+-independent
mechanism (Taurin et al., 2002). In cultured cortical neurons, ouabain-induced concentrationdependent neuron death that involved apoptosis and necrosis, which is mediated by intracellular
depletion of K+ and accumulation of Ca2+ and Na+ (Xiao, Wei, Xia, Rothman, & Yu, 2002).
These observations suggest that ouabain-Na/K-ATPase-mediated signaling differs from solely
ionic change ([Na+]i/[K+]i)-mediated signaling pathways. The possible interplay and different
mechanism(s) between them are still not totally understood.
In smooth muscle cells of rat arteries, both NCX and ouabain-sensitive Na+/K+-ATPase
α2- and α3-isoforms reside closely in plasma membrane regions adjacent to the sarcoplasmic
reticulum, a sub-plasmalemmal space called plasmERosome (Golovina, Song, James, Lingrel, &
Blaustein, 2003; Juhaszova & Blaustein, 1997a, 1997b; Moore et al., 1993). While low doses of
ouabain do not increase bulk cytosolic Na+ levels, it can stimulate a local transient rise of [Na+]i
in the plasmERosome, which can lead to a local transient increase of [Ca2+]i via the NCX and
increased muscle contractility (Arnon, Hamlyn, & Blaustein, 2000a, 2000b; Lee et al., 2006).
In cells without expression of plasma membrane NCX, alteration of [Na+]i/[K+]i ratio, by
high ouabain concentrations or palytoxin through inhibition of Na+/K+‐ATPase, is able to
activate some protein kinase signaling pathways (Contreras, Shoshani, Flores-Maldonado,
Lazaro, & Cereijido, 1999; Kuroki et al., 1997; S. Li & Wattenberg, 1998). This suggests that, in
cells lacking NCX expression, changes in [Na+]i or [K+]i or both may also stimulate Ca2+independent Na+/K+‐ATPase signaling functions.
These observations indicate a complicated interplay amongst Na/K-ATPase ion-exchange
activity, signaling, and ROS in regulation of different cellular events. The Na/K-ATPase
signaling-ROS axis might play an important role to dissect these regulations since chronic
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regulation of ion homeostasis could be a consequence of Na/K-ATPase signaling and ROS
regulation.
Na/K-ATPase signaling and ROS: the positive oxidant amplification loop
The interplay amongst Na/K-ATPase signaling, ROS, and oxidative modifications has
been a topic for decades. The effect of ROS on the Na/K‐ATPase activity has been welldocumented (Figtree, Keyvan Karimi, Liu, & Rasmussen, 2012; Figtree et al., 2009; W.-h.
Huang, Y. Wang, A. Askari, N. Zolotarjova, & M. Ganjeizadeh, 1994; W. H. Huang, Wang, &
Askari, 1992; Petrushanko et al., 2012; THÉVENOD & FRIEDMANN, 1999; Z. Xie et al.,
1999; Z. J. Xie, Wang, Askari, Huang, & Klaunig, 1990; Yan et al., 2013; Yan et al.,
2016). Different oxidative modification mechanisms and subunits of the Na/K-ATPase showed
different outputs.
In rabbit ventricular myocytes, glutathionylation of cysteine residue (Cys-46) of the
Na/K‐ATPase β1 subunit inhibits the Na/K‐ATPase activity by either stabilizing the enzyme in
an E2‐prone conformation, a process that could be reversibly regulated by glutaredoxin 1 and
FXYD, the proposed γ subunit of the Na/K-ATPase (Bibert et al., 2011; Figtree et al., 2012;
Figtree et al., 2009). In rat myocardium, S-glutathionylation of cysteine residues (Cys-454, -458,
-459, and-244) of the Na/K‐ATPase α1 subunit also inhibits the Na/K‐ATPase activity by
blocking the ATP‐binding site Na/K‐ATPase α1 subunit when the ATP concentration below
0.5mM. This s-glutathionylation of the α1 subunit as well as inhibition of the Na/K‐ATPase
activity can be reversed by deglutathionylation with glutaredoxin or dithiothreitol (Bogdanova,
Petrushanko, Hernansanz-Agustin, & Martinez-Ruiz, 2016; Petrushanko et al., 2012). In various
chronic inflammatory conditions, circulating cardiotonic steroids are elevated that are capable of
stimulating proinflammatory response in murine and human macrophages. This process involves
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ouabain-stimulated activation of NF-κB through a signaling complex of Na/K-ATPase, CD36,
and TLR4, leading to increases in proinflammatory cytokines MCP-1, TNFα, IL-1β, and IL-6
(Y. Chen et al., 2017; Y. Chen, Kennedy, et al., 2015; Kennedy et al., 2013).
In rat neonatal myocytes, ouabain-stimulated activation of Na/K-ATPase signaling
function increases mitochondrial ROS generation that functions as an essential second messenger
(J. Liu et al., 2000; Z. Xie et al., 1999). More importantly, increases in ROS can cause
conformational changes in Na/K-ATPase like ouabain (Bibert et al., 2011; Figtree et al., 2012;
Figtree et al., 2009; W.-h. Huang et al., 1994; Petrushanko et al., 2012; Z. J. Xie et al., 1990) .
One question asked was that if ROS is able to stimulate the signaling function of Na/K-ATPase
like ouabain, and if ouabain (or ROS) → Na/K-ATPase signaling→ ROS→ Na/K-ATPase
signaling could form a positive amplification loop that could amplify Na/K-ATPase and
subsequent signaling events and functional changes. This is of particular interest since it was
well accepted that ROS play an important role in the pathogenesis of cardiovascular diseases and
chronic kidney diseases, and many others.
In primary cultures of cardiac myocytes, it was demonstrated that partial inhibition of
Na/K-ATPase by ouabain increased c-Src- and Ras-dependent, and mitochondrial KATP channelrelated ROS generation, and ouabain-induced cardiac hypertrophic growth involved ROSdependent signaling pathways (Z. Xie et al., 1999). In Langendorff-perfused rat hearts,
pretreatment with ouabain demonstrated a cardioprotective effects against ischemia-reperfusion
injury by an improved recovery of contractile function and a reduction of infarct size. This
ouabain effect is due to activation of Na/K-ATPase signaling function that involves Src,
mitochondrial KATP channel, and ROS (Pasdois et al., 2007). Exogenous ROS (for example,
induced by glucose oxidase), acting as ouabain, also caused ROS-dependent cardiac
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hypertrophic growth. Inhibition of c-Src and ERK1/2 abrogated the effects of ROS-induced
protein synthesis that was not affected by chelating intracellular Ca2+ by BAPTA-AM (L. Liu et
al., 2006). Moreover, ouabain-induced increase in [Ca2+]i was ROS-independent and involved
mainly the inhibition of Na/K-ATPase ion transport function (J. Liu et al., 2000). These
observations indicated that ROS act like ouabain, and the Na/K-ATPase could be a target for
ROS-initiated signaling.
In porcine LLC-PK1 cells (an immobilized renal proximal tubule cell line), exogenous
peroxide (H2O2) activated Na/K-ATPase signaling pathways including phosphorylation of c-Src
and ERK1/2 (Y. Wang et al., 2014). By using LLC-PK1 cells, it was further demonstrated that
low concentration of ouabain also stimulated Na/K-ATPase signaling function which leads to
increased ROS generation and protein carbonylation modification of Na/K-ATPase (direct
carbonylation of two amino acid residues, Pro222 and Thr224, in the actuator domain of the α1
subunit) (Yan et al., 2013). Pretreatment with antioxidant N-acetyl-L-cysteine (NAC) or
disruption of the Na/K-ATPase/c-Src signaling complex attenuated ouabain- and glucose
oxidase-stimulated Na/K-ATPase/c-Src signaling, protein carbonylation, redistribution of Na/KATPase, and inhibition of active transepithelial 22Na+ transport. It indicated that ROS are critical
in initiating ouabain-stimulated Na/K-ATPase/c-Src signaling, and carbonylation modification of
the α1 subunit is involved in a feed-forward mechanism of regulation of ouabain-mediated Na/KATPase signal function and subsequent Na+ transport. Interestingly, there is an undefined decarbonylation mechanism of ouabain-stimulated protein carbonylation after removal of ouabain,
this could be another new regulatory mechanism of Na/K-ATPase signaling because it was
believed that protein carbonylation modification could not be reversed. Furthermore, stable
overexpression of rat α1 mutant Pro224/Ala (Pro224 of rat α1 is the same as the Pro222 of pig
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α1) prevented ouabain-stimulated signal function of Na/K-ATPase, protein carbonylation, Na/K‐
ATPase endocytosis, and active transepithelial 22Na+ transport (Yan et al., 2016). Taken together,
we proposed that, in LLC-PK1 cells, there is a positive-feedback amplification loop of Na/KATPase signaling and ROS generation, in which carbonylation of the Pro222 of the α1 subunit
plays a critical role. In this working model, both Na/K-ATPase specific ligands cardiotonic
steroids (including ouabain) and ROS increases (induced by other stimuli including exogenous
added glucose oxidase) could activate the Na/K-ATPase signaling. The Na/K-ATPase/c-Src
complex functions as a “receptor” of ROS signaling. This Na/K-ATPase signaling-ROS axis
may explain the role of Na/K-ATPase signaling in the development of different
pathophysiological conditions. However, it is not clear (1) if a “decarbonylation” process could
regulate the carbonylation modification, and (2) to which point the oxidant amplification loop
will be forced to stop.
Na/K-ATPase signaling and pNaKtide: a specific antagonist of c-Src kinase that breaks
oxidant amplification loop.
One question for above-mentioned “Na/K-ATPase signaling-mediated oxidant
amplification loop” is, could this amplification loop be controlled and targeted for possible
therapeutic implication(s)? In the Na/K-ATPase/c-Src signaling complex model, it was
demonstrated that the α1 ND1 domain binds to the c-Src tyrosine kinase domain and the α1 CD2
domain binds to the c-Src SH2 domain in the “resting” state (Tian et al., 2006). Upon ouabain
stimulation, c-Src is activated (phosphorylation of Tyr418) due to the disruption of the binding
between the α1 ND1 domain and the c-Src tyrosine kinase domain. Based on this “working”
model, mapping of these domains led to the identification of a peptide named NaKtide (derived
from the Ser415-Gln434 of the pig α1 ND1 domain). In order to further explore this
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relationship, a cell permeable version of NaKtide, named pNaKtide was created. A 13 amino
acid TAT leader sequence makes pNaKtide positive and therefore cell permeable. pNaKtide
targets the α1/Src receptor complex close to the plasma membrane inside the cell (Figtree et al.,
2009; Z. Li et al., 2011). Both NaKtide and pNaKtide act as specific antagonists of c-Src
phosphorylation (Figure 12), further demonstrated that the binding of the α1 and c-Src and the
conformational change are critical in activation of Na/K-ATPase signaling.

Figure 12. A schematic illustration of action of pNaKtide.
Under control state, c-Src SH2 domain binds to α1 CD2 segment, and c-Src KD binds to
α1 ND1 that keep c-Src inactive. Upon ouabain binding to the α1 subunit, the α1 subunit
favors E-2P conformational status, and c-Src KD released from α1 subunit that leads to
phosphorylation of Tyr418 in c-Src KD. NaKtide and pNaKtide are derived from 20 aa
(Ser415-Gln434) in α1 ND1, which can bind to the c-Src KD to competitive binding of α1
ND1 and KD, thus prevent phosphorylation of Tyr418 in c-Src KD. In the illustration,
ouabain is used as a representative of cardiotonic steroids.SH2, c-Src SH2 domain; KD, cSrc kinase domain; CD2, α1 subunit CD2 segment; ND1, α1 subunit ND1 segment.
Oxidative stress plays an important role in many pathophysiological conditions. The role
of pNaKtide in Na/K-ATPase signaling mediated oxidant amplification loop has been
investigated in different cell types and animal models. For example, systemic administration of
pNaKtide significantly and effectively attenuates (1) 5/6th partial nephrectomy (PNx) induced
uremic cardiomyopathy phenotypes in C57BL/6 mice (J. Liu et al., 2016), (2) a high fat diet
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induced adipogenesis, a model of obesity and metabolic syndrome (Sodhi et al., 2015), (3) a
Western diet (containing high fat and high fructose) induced obesity, hepatic steatosis, and
fibrosis in C57BL/6 mice, as well as steatohepatitis and aortic atherosclerosis in ApoE knockout
mice (Sodhi et al., 2017), (4) a Western diet accelerated aging process involving nuclear
oxidative stress in C57BL/6 mice (Sodhi et al., 2018), as well as (5) unilateral ureteral
obstruction (UUO) mediated interstitial fibrosis in C57BL/6J mice (Cheng, Song, & Wang,
2018). In these animal models, administration of pNaKtide specifically breaks Na/K-ATPase
signaling mediated oxidant amplification loop, demonstrated by pNaKtide-induced attenuation of
c-Src activation, protein carbonylation, and other regulations. More molecular mechanistic
studies are necessary for possible therapeutic usage.
Na/K-ATPase signaling-mediated transporter endocytosis and renal sodium handling
Over the last decade, the role of Na/K-ATPase signaling in renal proximal tubular sodium
handling, and the role of oxidative modification of the Na/K-ATPase α1 subunit in Na/KATPase signaling were explored both in vitro and in vivo. The findings may explain some
mechanism(s) related to the Na/K-ATPase signaling-ROS amplification loop and subsequent
regulation of salt-sensitivity.
It is well-documented that the renal proximal tubule mediates over 60% of the filtered
Na+ reabsorption, mainly through apical Na+ entry via NHE3 and basolateral Na+ extrusion
through the Na/K-ATPase. Coordinated and coupled regulation of NHE3 and the Na/K-ATPase
is critical in maintaining intracellular Na+ homeostasis and extracellular fluid volume (J. Liu &
Xie, 2010; Alicia A. McDonough, 2010; A. A. McDonough, Leong, & Yang, 2003).
In LLC-PK1 cells, like dopamine (Bacic et al., 2003; Chibalin, Katz, Berggren, &
Bertorello, 1997; Chibalin et al., 1999; Hu et al., 2001), low concentrations of ouabain stimulate
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endocytosis of the α1/β1 subunits, NHE3 (Na+/H+ exchanger, isoform 3), and c-Src into early
and/or late endosomes, leading to a net decreases in abundance of Na/K-ATPase and NHE3 in
cell surface, and thus decreases in transcellular 22Na+ transport (J. Liu, 2005; J. Liu et al., 2004;
J. Liu et al., 2005; J. Liu et al., 2002; J. Liu & Shapiro, 2007; J. Liu & Xie, 2010; Periyasamy et
al., 2005; Yan et al., 2012). This phenomenon is mainly through a clathrin-dependent endocytic
pathway, and requires caveolin-1 and activation of c-Src and PI3K. Furthermore, ouabaininduced endocytosis of Na/K-ATPase and NHE3, thus decreases in transcellular 22Na+
reabsorption, is dependent on ouabain-stimulated signaling function of Na/K-ATPase without
significantly affect [Na+]i.(H. Cai, Wu, L., Qu, W., Malhotra, D., Xie, Z., Shapiro, JI, and Liu, J.,
2008; J. Liu et al., 2004; Oweis et al., 2006). Inhibition of c-Src and PI3K activity prevented
ouabain-induced endocytosis of Na/K-ATPase and NHE3. Pretreatment of LLC-PK1 cells with
membrane-permeable Ca2+ chelator BAPTA-AM attenuated ouabain-induced regulation of
NHE3 (H. Cai, Wu, L., Qu, W., Malhotra, D., Xie, Z., Shapiro, JI, and Liu, J., 2008), suggesting
ouabain-induced Ca2+ signaling might be involved in regulation (Aizman et al., 2001). In male
Sprague-Dawley rats fed a high salt (4.0% NaCl) or normal salt (0.4% NaCl) diet for 1 week, a
high salt diet redistributes the Na/K-ATPase α1 subunit from plasma membrane fraction to
early/late endosomes, accompanying a reduction of proximal tubular Na/K-ATPase ionexchange activity and enzymatic activity, but increases in urinary excretion of marinobufagenin
(MBG) and sodium. These effects were attenuated by administration of anti-MBG antibody prior
to salt load (Periyasamy et al., 2005). Moreover, this observation was further confirmed in vivo.
By using Dahl salt-sensitive and salt-resistant rats (Jr strains) as models, in vivo studies
demonstrated that impairment of renal proximal tubular Na/K-ATPase signaling is a causative of
experimental Dahl salt sensitivity (J. Liu et al., 2011). In Dahl salt-resistant but not salt-sensitive
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rats, a high salt (2% NaCl, 1 week) diet activated proximal tubular Na/K-ATPase signaling and
stimulated coordinated redistribution of the Na/K-ATPase and NHE3, leading to increases total
and fractional urinary sodium excretion as well as normal blood pressure. However, the
underlying mechanism(s) that the difference of Na/K-ATPase signaling function between Dahl
salt-sensitive and salt-resistant rats, as well as the translation of Na/K-ATPase signaling to NHE3
regulation are still unclear.
It is well established that both oxidative stress and high blood pressure are a cause and
consequence of each other. Based on the findings of amplification loop of Na/K-ATPase
signaling and ROS generation, we tested whether oxidative stress could activate the signaling
function of Na/K-ATPase and induce above-mentioned endocytosis process and regulation of
renal sodium handling. In our “working” model, increases in ROS generation, either by ouabain
or by other stimuli like glucose oxidase, is critical in activation of Na/K-ATPase signaling which
mediates transporter trafficking, transcellular Na+ transport, and urinary sodium excretion (Yan
et al., 2013; Yan et al., 2016). In one hand, pretreatment with anti-oxidant NAC abrogates
ouabain-stimulated Na/K-ATPase signaling and transcellular Na+ transport, suggesting that a
certain level of basal ROS is required for initiation of Na/K-ATPase signaling. On the other
hand, without the presence of ouabain, increases in ROS by extracellularly added glucose
oxidase is able to activate Na/K-ATPase signaling, indicating that activation of Na/K-ATPase
signaling does require its specific ligands and general stimuli like oxidative modification alone
are able to activate the Na/K-ATPase signaling (P. T. Shah, Martin, Yan, Shapiro, & Liu, 2016).
However, the effect(s) and consequence(s) of ouabain- and ROS-induced endocytosis of
Na/K-ATPase/c-Src/EGFR (J. Liu et al., 2004; J. Liu et al., 2005) are not clear. It has been
shown that endocytosis of signaling molecules could be a way to terminate or propagate the
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signaling, and could further regulate endocytosis itself (Cavalli, Corti, & Gruenberg, 2001; Di
Guglielmo, Baass, Ou, Posner, & Bergeron, 1994; Kuwada et al., 1998; McPherson, Kay, &
Hussain, 2001; Roy, Wyse, & Hancock, 2002; Ware, Tice, Parsons, & Lauffenburger, 1997;
Wilde et al., 1999; Wiley & Burke, 2001). In this regard, it is possible that ouabain- and ROSinduced endocytosis could be an effective way to terminate Na/K-ATPase signaling mediated
oxidant amplification loop by degradation of carbonylated Na/K-ATPase, to maintain certain
basal level of ROS and carbonylated protein (J. Liu, Lilly, & Shapiro, 2018).
Perspectives: The “working” models of Na/K-ATPase signaling
There are different proposed “working” models which explain the mechanisms
underlying the activation of the Na/K-ATPase signaling function, including (1) the direct
interaction of the Na/K-ATPase α1 subunit with c-Src kinase which forms a functional Na/KATPase/c-Src signaling receptor complex, a model has been demonstrated both in vitro and in
vivo (Bagrov, Shapiro, & Fedorova, 2009; Z. Li & Xie, 2009; Pierre & Xie, 2006; Tian et al.,
2006); (2) c-Src is activated primarily by an ATP-sparing effect (observed in a cell-free system)
(Gable, Abdallah, Najjar, Liu, & Askari, 2014; Weigand, Swarts, Fedosova, Russel, &
Koenderink, 2012); and (3) c-Src is activated by transiently interaction with a Na/K-ATPase
α1/caveolin-1 complex (also observed in a cell-free system) (Figure 13).
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Figure 13. Schematic illustration of different “working” models.
In the illustration, ouabain is used as a representative of cardiotonic steroids. A, the model of
Na/K-ATPase/c-Src (binding) receptor complex. B, the model of c-Src activation by transiently
binding to Na/K-ATPase/Cav-1 complex. C, the model of c-Src activation regulated by
+
+
ATP/ADP ratio, ATPase inhibitor vanadate, and low concentration of Na and K . In this model,
there is no binding between Na/K-ATPase and c-Src. The role of Cav-1 was not tested. Please
refer to the references for details. Cav-1, caveolin-1; ROS, reactive oxygen species.
In these models, there is no doubt that c-Src activation is a proximal step in the Na/K-ATPase
signaling. It is not a surprise that different “working” models are proposed based on different
experimental systems, and an ideal “working” model is developed based on new developments
and new technologies. As mentioned above, ouabain (and other cardiotonic steroids),
ROS/reactive nitrogen species (RNS), changes of ionic concentrations (bulky or local), and other
stimuli can activate different signaling pathways to excute different functional regulations.
Moreover, these different signaling pathways and functional regulation are also cell-dependent.
A common charateristic in these “working” models is that they are, at least partially, dependent
on the conformation change. Specifically, the E2-P conformational state of the Na/K-ATPase is
favored, and stabilized by Na/K-ATPase inhibitors (ouabain, vanadate, oligomycin), energy
status (ATP/ADP ratio), and change in [Na+] and [K+]. While the E2-P conformational state of
the Na/K-ATPase is favored, a “slower” dynamic E-2P ↔ E1-P conformational change (in the
presence of inhibitors and/or energy status) might be an effective way to maintain and control the
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signaling strength and function. Nevertheless, these hypotheses need to be experimentally
demonstrated.
Funding: This work was supported by NIH R15 1R15DK106666 (to J. Liu) and NIH RO1
HL071556 (to J.I. Shapiro).
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CHAPTER 4
RELATIONSHIP BETWEEN THE NA/K-ATPASE OXIDANT AMPLIFICATION
LOOP AND ADIPOGENESIS IN 3T3-L1 CELLS
Introduction
Obesity has reached epidemic proportions worldwide; the prevalence of obesity has
increased by 28% in adults and 47% in children from 1980 to 2013 and these numbers are still
increasing (Smith & Smith, 2016). Obesity is a chronic multifactorial disease that has been
associated with metabolic syndrome, diabetes mellitus, cardiovascular disease, chronic kidney
disease, hypertension, insulin resistance, and even dementia (Andre, Dinel, Ferreira, Laye, &
Castanon, 2014; Greenberg & McDaniel, 2002; J. E. Hall, Jones, et al., 2003; Kothari et al.,
2017; Lafontan, 2014) . The typical “Western diet”, containing excessive fat and fructose, may
predispose one to both obesity and these complications (Ohtomo et al., 2017; Sodhi et al., 2017).
It has been demonstrated that chronic oxidative stress contributes to the development of
obesity (Le Lay et al., 2014; Srikanthan, Shapiro, et al., 2016; Vincent & Taylor, 2006). In many
models of obesity, there is an increase in reactive oxygen species (ROS) and oxidative stress; it
is thought that increased ROS lead to obesity, and obesity increases ROS (Furukawa et al., 2004;
Srikanthan, Shapiro, et al., 2016). This increase in ROS related to obesity can be linked to
dysfunctional Na/K-ATPase signaling (Rebecca D. Pratt et al., 2019; Srikanthan, Shapiro, et al.,
2016).
Other than functioning as an “ion-pumping” pump, the Na/K-ATPase also functions as a
receptor, signal transducer, and scaffold through multiple protein–protein interactions [reviewed
in (J. Liu et al., 2018; R.D. Pratt, Brickman, Cottrill, Shapiro, & Liu, 2018; Z. Xie, 2003)].
Binding of cardiotonic steroids (specific inhibitors and ligands of Na/K-ATPase) such as ouabain
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to the Na/K-ATPase α1 subunit initiates different signaling pathways, including activation of cSrc kinase and Ras/Raf/ERKs cascade, and increases in ROS generation ((J. Liu et al., 2016;
Sodhi et al., 2015; Sodhi et al., 2018; Sodhi et al., 2017; Z. Xie & Xie, 2005; Yan et al., 2013;
Yan et al., 2016)). Recently, we further demonstrated that, while endogenous and/or exogenous
factors stimulate ROS generation via Na/K-ATPase signaling, increases in ROS alone are also
capable of stimulating the Na/K-ATPase signaling function (Yan et al., 2013). This forms a
positive oxidant amplification loop in which the Na/K-ATPase signaling functions as an
amplifier of oxidants through its downstream signaling cascade. Our lab has demonstrated that
systemic administration of pNaKtide, a cell permeable peptide designed to inhibit Na/K-ATPase
signaling, was able to reduce oxidative stress, obesity, nonalcoholic steatohepatitis (NASH), and
atherosclerosis induced by a Western diet (Sodhi et al., 2015; Sodhi et al., 2017). Based on this,
we were interested in examining the Na/K-ATPase signaling cascade in the specific cell involved
in the pathogenesis of obesity: adipocytes.
Lentiviral vectors have evolved over the last decade as powerful, reliable, and safe tools
for stable gene transfer in a wide variety of mammalian cells (Cao et al., 2012; Cao, Sodhi,
Inoue, et al., 2011; Huentelman et al., 2005; Schambach & Baum, 2008). Lentivirus used for
vector construction has been made replication deficient. Using lentivirus allows specific
targeting of protein(s) to specific tissue depending on the specificity of the promoter; utilization
of lentiviral vector is safe and highly effective, and has been demonstrated as an ideal tool for
studies on obesity, hypertension, and related diseases (Cao et al., 2012).
Based on our previous observation that blockage of the Na/K-ATPase signaling cascade
through systemic administration of pNaKtide decreased adipogenesis in 3T3-L1 cells by
decreasing ROS (Sodhi et al., 2015), we aim to determine whether specific stimulation of the
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Na/K-ATPase in adipocytes by administration of ouabain increases adipogenesis, and if this
could be inhibited with pNaKtide administration. 3T3-L1, a murine preadipocyte cell line, has
been widely used for studying mammalian adipogenesis (MacDougald & Lane, 1995; Rosen &
MacDougald, 2006). These pre-adipocytes undergo a well-characterized process of
differentiation upon induction with insulin, dexamethasone, and indomethacin, and differentiated
3T3-L1 cells exhibit many of the characteristics found in mature adipocytes from mammalian fat
tissue(MacDougald & Lane, 1995). Further, we will explore whether lentiviral-mediated delivery
of NaKtide (a non-cell permeable version of pNaKtide) will show a similar effect in
adipogenesis as systemic administration of pNaKtide.
Results
Ouabain alone does not induce adipogenesis in 3T3-L1 cells but enhances the effects in
adipogenic media
3T3-L1 cells were exposed to both maintenance media (MM) [Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum and 1%
antibiotic/antimycotic solution] and adipogenic media (AM) (MacDougald & Lane, 1995; Puri et
al., 2012; Rosen, Walkey, Puigserver, & Spiegelman, 2000) and treated with increasing doses of
ouabain. The adipogenic media consisted of DMEM-high glucose, 10% FBS, 10 μg/mL insulin,
0.5 mM dexamethasone and 0.1 mM indomethacin. Our results showed that in MM there was no
induction of adipogenesis at any concentration of ouabain, but when administered along with
AM for 7 days ouabain enhance adipogenesis in a dose-dependent manner on top of AM (Figure
14 and 15). No cytotoxic effects of ouabain were noted at the lower doses used, but when dosing
of ouabain reached 500 nM and above, there was a sharp increase in cytotoxicity; this was
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anticipated as at high doses, ouabain can be toxic (Figure 16) (Aizman et al., 2001; Tian et al.,
2006; Yan et al., 2012).

Figure 14. Ouabain increased adipogenesis in 3T3-L1 cells cultured in Adipogenic
Media.
Oil Red O staining in 3T3 cells treated with varying concentrations of ouabain in
adipogenic media. n=6 Per group. * p-value<0.05 vs CTR,** p-value<0.001 vs CTR,#
p-value <0.05 vs Fructose, ## p-value <0.001 vs Fructose,+ p-value <0.05 vs 1 nM
ouabain, ~ p-value <0.05 vs 10 nM ouabain,$ p-value <0.05 vs 25 nM ouabain.
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Figure 15. Ouabain alone did not induce adipogenesis but enhanced the effects
in Adipogenic Media.
Oil Red O staining in 3T3-L1 cells treated with varying concentrations of ouabain in
maintenance media and adipogenic media. n=6 Per group. * p-value <0.05 vs CTR,
** p-value<0.001 vs CTR, ## p-value <0.001 vs 50 nm ouabain ,++ p-value <0.001
vs ouabain 100 nM, ~~ p-value <0.05 vs ouabain 250 nM
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Figure 16. Ouabain and pNaKtide on cytotoxicity in 3T3-L1 cells.
Measured LDH activity in (A) 3T3-L1 cells treated with varying concentrations of ouabain
in AM and (B) 3T3-L1 cells treated with 100 nM ouabain, 700 nM pNaKtide, and both
ouabain and pNaKtide in adipogenic media. n=6/group. ** p-value<0.001 vs ouabain 50 nM,
## p-value <0.001 vs ouabain 100 nM, $$p-value <0.001 vs ouabain 250 nM
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pNaKtide decreases adipogenesis and expression of adipogenic and inflammatory markers
in 3T3-L1 cells
3T3-L1 cells were exposed to AM, 100 nM of ouabain and 700 nM of pNaKtide for 7
days (Sodhi et al., 2015). As shown in Figure 16 there were no cytotoxic effects at these doses or
with AM alone. Ouabain significantly increased adipogenesis as evidenced by Oil Red O
staining, and pNaKtide decreased adipogenesis. Interestingly, even in the presence of ouabain,
pNaKtide was able to decrease Oil Red O staining (Figure 17).

Figure 17. pNaKtide decreases adipogenesis.
Oil Red O staining of 3T3-L1 cells treated with 100 nM ouabain, 700 nM pNaKtide, and
both ouabain and pNaKtide in adipogenic media. n=6/group. ** p-value<0.001 vs AM,
# p-value <0.05 vs ouabain 100 nM,+ p-value <0.05 vs pNaKtide
Administration of ouabain decreased adiponectin (a protein hormone involved in
regulating glucose levels and fatty acid breakdown) levels, while significantly increasing the
expression of adipogenic markers FAS, MEST, and PPARγ and inflammatory markers TNFα,
IL-6, and MCP-1 (Figure 18 and 19). Administration of pNaKtide, whether alone or in the
presence of ouabain, increased adiponectin levels and reduced the expression of the adipogenic
and inflammatory markers. This indicates that pNaKtide prevented or reversed adipocyte
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dysfunction and inflammation associated with the dysfunction, even in the presence of specific
stimulation of the Na/K-ATPase by ouabain.

Figure 18. pNaKtide improves inflammatory profile of 3T3-L1 cells treated with AM
and/or ouabain.
Measurement of (A) TNFα, (B) IL-6, (C) MCP-1 and (D) adiponectin in media of 3T3-L1
cells treated with 100 nM ouabain, 700 nM pNaKtide, and both ouabain and pNaKtide in
adipogenic media. n=6/group. ** p-value<0.001 vs AM, ## p-value <0.001 vs ouabain
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Figure 19. Ouabain increases expression of adipogenic markers in 3T3-L1 cells
cultured in Adipogenic Media.
Western blot of (A) FAS, (B) PPARγ, and (C) MEST in 3T3-L1 cells treated with
100 nM ouabain, 700 nM pNaKtide, and both ouabain and pNaKtide in adipogenic
media. n=6/group. ** p-value<0.001 vs AM, ## p-value <0.001 vs ouabain

pNaKtide decreases c-Src phosphorylation and protein carbonylation in 3T3-L1 cells
When exposed to ouabain, c-Src phosphorylation significantly increased in 3T3-L1 cells
(Figure 20). This was accompanied by an increase in protein carbonylation, which is a wellknown marker of oxidative stress (Rebecca D. Pratt et al., 2019; P. T. Shah et al., 2016; Yan et
al., 2013). Administration of pNaKtide reduced c-Src phosphorylation and decreased protein
carbonylation; this suggests that pNaKtide has a positive role on cellular redox in the adipocyte,
and can prevent adipogenesis-mediated oxidative stress through partially blocking the Na/KATPase signaling cascade.
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Figure 20. Ouabain stimulated c-Src phosphorylation and protein carbonylation in
3T3-L1 cells cultured in Adipogenic Media.
Western blot of (A) Src and (B) protein carbonylation in 3T3-L1 cells treated with 100 nM
ouabain, 700 nM pNaKtide, and both ouabain and pNaKtide in adipogenic media.
n=6/group.** p-value<0.001 vs AM, ## p-value <0.001 vs ouabain.

pNaKtide increases expression of the α1 subunit of the Na/K-ATPase over the course of 7day treatment window in 3T3-L1 cells
The α1 subunit of the Na/K-ATPase is regularly endocytosed, repaired, and recycled
back to the plasma membrane to be re-integrated; it has been shown that increased levels of
oxidative stress and ROS can impair this process and decrease the amount of endocytosed α1
subunit that is recycled (Cavalli et al., 2001; Chibalin et al., 1997; Comellas et al., 2006; Dada et
al., 2003; J. Liu, 2005; J. Liu et al., 2004; J. Liu et al., 2005). To this end, we examined α1
expression at Days 1, 3, 5, and 7 of after treatment with MM and AM. In MM there is no change
in α1 expression over the course of 7 days (Figure 21). Interestingly, both AM alone and AM
with 100 nM of ouabain reduces α1 expression by approximately 50%, seen in Day 3 and by the
end of treatment (Day7) (Figure 21 and 22). pNaKtide, prevented this decrease in α1 expression
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(pNaKtide alone) or significantly slowed the process even in the presence of ouabain
(ouabain+pNaKtide) (Figure 22).

Figure 21. Adipogenic Media (AM) but not Maintenance Media (MM) decreased
α1 expression during 7 day time course.
Western blot of α1 expression in 3T3-L1 cells in (A) maintenance media or (B)
adipogenic media at time points of 1, 3, 5, or 7 days of exposure to media. n=6/group.
*p-value<0.05 vs MM Day 1, **p-value<0.001 vs MM Day 1, #p-value<0.05 vs AM
Day 1, ##p-value<0.001 vs AM Day 1, ++p-value<0.001 vs MM Day 3, $p-value<0.05
vs AM Day 3, $$p-value<0.001 vs AM Day 3, ~~p-value<0.001 vs MM Day 5, ^pvalue<0.05 vs AM Day 5, &p-value <0.05 vs MM Day 7
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Figure 22. pNaKtide prevents decrease in α1 expression during 7 day time
course.
Western blot of α1 expression in 3T3-L1 cells in (A) adipogenic media with
100 nM ouabain, (B) adipogenic media with 700 nM pNaKtide, or (C)
adipogenic media with both ouabain and pNaKtide at timepoints of 1, 3, 5, or
7 days of exposure to media and treatment. n=6/group. * p-value<0.05 vs
ouabain Day 1, # p-value<0.05 vs pNaKtide Day 1, +p-value<0.05 vs
ouabain+pNaKtide Day 1, $ p-value<0.05 vs pNaKtide Day 3, ~ p-value<0.05
vs ouabain Day 5,^ p-value<0.05 vs pNaKtide Day 5, &p-value<0.05 vs
ouabain Day 7
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Transfection of NaKtide to 3T3-L1 cells effectively reduces AM-induced adipogenesis
Lentiviral constructs were used to deliver NaKtide specifically into adipocytes with an
adiponectin promoter (Figure 23). Adiponectin mRNA transcripts are highly expressed in
adipocytes as well as preadipocytes differentiating into adipocytes; therefore, adiponectin is the
most suitable candidate for targeting adipocytes (Lara-Castro, Fu, Chung, & Garvey, 2007;
Maeda et al., 1996; Matsuzawa, Funahashi, Kihara, & Shimomura, 2004).

Figure 23. Lentiviral Constructs.
An adiponectin promoter drove expression of the NaKtide cassette linked
by means of a 2A peptide to eGFP for bicistronic expression. (A) Lentiadiponectin-GFP is the empty viral vector and (B) lenti-adiponectin-GFPNaKtide contains the sequence for NaKtide.

After transfection with the lentivirus, NaKtide was shown to decrease adipogenesis in
comparison to the AM alone and- expression of control vector (an empty lentiviral vector
expressing GFP alone) (Figure 24). Transduction efficiency was calculated (see Materials and
Methods) to determine the percentage of cells that were successfully infected with lentivirus;
both the lenti-GFP and lenti-NaKtide group had transduction efficiencies of approximately 80%
and there was no significant difference between the groups (Figure 24).
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Figure 24. Transfection of NaKtide to 3T3-L1 cells effectively reduces adipogenesis.
(A) Brightfield and GFP images taken of 3T3-L1 cells transfected with lenti-adiponectin-GFP
and lenti-adiponectin-NaKtide, respectively. (B) Transduction efficiency of both lentiadiponectin-GFP and lenti-adiponectin-NaKtide. (C) Oil Red O staining of cells transfected
with lenti-adiponectin-GFP and lenti-adiponectin-NaKtide. n=8/group. ** p-value<0.001 vs
Control, ## p-value <0.001 vs GFP

Discussion
This study highlights the therapeutic potential of targeting adipocytes in obesity.
Oxidative stress has been implicated with the chronic inflammatory state that has been shown to
be a crucial factor in obesity (Gutierrez et al., 2009; Trayhurn, 2007; Wellen & Hotamisligil,
2003). We have demonstrated in this report that pNaKtide effectively reduces adipogenesis in
vitro by antagonizing Na/K-ATPase–mediated amplification of ROS signaling; our results with
lenti-adiponectin-GFP-NaKtide show a similar trend as is shown with the reduction of
adipogenesis.
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We observed that in murine preadipocytes, exposure to pNaKtide attenuated oxidative
stress, decreased lipid accumulation, and decreased presence of adipogenic regulators PPARγ,
CEBPa, and FAS. There was a significant upregulation in the production of adiponectin levels in
the pNaKtide treated cells as well. The inflammatory profile in these cells (TNFa, MCP-1, and
IL-6) showed significant reductions, indicating a decrease in oxidative stress. Interestingly, these
effects were seen even in the presence of ouabain, a specific stimulator of the Na/K-ATPase.
This implies that pNaKtide acts on the Na/K-ATPase oxidant amplification loop in the
adipocytes; increased ROS and oxidative stress, increased Na/K-ATPase signaling, and increased
adipogenesis seen with administration of ouabain in adipogenic conditions could contribute to a
redox imbalance that is improved with treatment of pNaKtide.
It is important to note that the increase in adipogenesis and oxidative stress was only seen
when combined with adipogenic media. 3T3-L1 cells in maintenance media did not see any
adipogenesis, even in the presence of ouabain. This is because the growth arrest seen in in vitro
adipogenesis occurs in tandem with the expression of transcription factors peroxisome
proliferator activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (CEBPα) and
addition of a “pro-differentiative hormonal regimen”, in our case, adipogenic media(Rosen et al.,
2000).
We also observed a marked decrease in α1 expression in 3T3-L1 cells treated with
adipogenic media and ouabain, and this decrease was rescued upon addition of pNaKtide in the
presence and absence of ouabain. Literature shows that there is an approximately 55% decrease
in α1 expression upon differentiation in adipocytes; we saw this effect in adipogenic media and
upon addition of ouabain. At higher doses of ouabain there was an increase in toxicity. The IC50
of ouabain, or the half maximal inhibitory concentration (a measure of the potency of a substance
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in inhibiting a specific biological or biochemical function) is 100 uM for α1(Lelievr, Crambert,
& Allen, 2001). However, the IC50 of ouabain for α2 is 1 uM; in differentiated adipocytes the
major isoform of the Na/K-ATPase present is α2. The increased concentration (and the isoform
switch and pumping function from α2 seen in adipocytes) may explain the increased toxicity
seen at higher doses. Another area of interest is where the majority of signaling of the Na/KATPase comes from; the endocytosed Na/K-ATPase versus the plasma membrane Na/KATPase. Increased oxidative stress causes an increase in endocytosis of the pump. The
internalized Na/K-ATPase may still have some signaling function, but this has not yet been
determined. This is an important future direction that could be crucial to further understanding
Na/K-ATPase signaling in the adipocyte.
These observations are of budding interest for several reasons. First, we have confirmed
the role of the Na/K-ATPase oxidant amplification loop in the process of adipogenesis. By
utilizing ouabain, a known stimulator of Na/K-ATPase signaling, we have shown that in tandem
with adipogenic conditions, increased Na/K-ATPase signaling increases adipogenesis and ROS;
this process was not previously linked to cardiotonic steroids or the Na/K-ATPase signal cascade
but our data shows a potentially larger role of the Na/K-ATPase oxidant amplification loop in
adipocyte biology and obesity pathology.
Next, utilization of pNaKtide, even in the presence of specific stimulation of the Na/KATPase may present a therapeutic effect. pNaKtide alone decreased adipogenesis, ROS, and the
inflammatory profile of the adipogenic cells, and the effect was able to surpass the effects of
ouabain. This implies that not only does pNaKtide have an effect on adipogenesis in vitro, but it
also suggests that the effect of pNaKtide is coming through direct action on the Na/K-ATPase
oxidant amplification loop to decrease impaired redox biology of the adipocyte itself. This
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further confirms the role of adipocytes in obesity and its comorbidities is much more important
than previously determined.
Finally, we used a lentiviral vector to deliver NaKtide to the 3T3-L1 cells. NaKtide and
pNaKtide are similar in structure, but NaKtide is non-cell permeable. pNaKtide contains a 13
amino acid TAT leader sequence that allows it to penetrate the cell membrane, and act inside the
cell. NaKtide, until now, has been unable to permeate the cell membrane without some measure
of toxicity (Z. Li et al., 2009). By utilizing a lentiviral vector, NaKtide is expressed inside the
cells. Expression of lenti-adiponectin-GFP-NaKtide showed a promising decrease in
adipogenesis, and will be used in a rodent model of obesity to see if it has similar effects to
systemic administration of pNaKtide(Sodhi et al., 2015)
We have clearly demonstrated that the Na/K-ATPase amplification loop has an impact on
adipogenesis. ROS amplification can occur through this pathway, and significantly increase
adipogenesis and further increase Na/K-ATPase signaling. These results suggest that the Na/KATPase oxidant amplification loop may serve as a potential target in dysfunctional redox states
and oxidative stress therapies associated with obesity.
Materials and Methods
Cell Culture Experiments
Frozen mouse preadipocytes (3T3-L1) were resuspended in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum and 1%
antibiotic/antimycotic solution. The cultures were maintained at 37°C in a 5% CO2 incubator,
and the medium was changed after 24 hours and every 3 to 4 days thereafter. When the 3T3-L1
cells were confluent, the cells were recovered by the addition of trypsin.
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3T3-L1 cells (passages 2 to 3) were plated in 24-well plates at a density of 10,000
cells/cm2 and cultured in DMEM until ~75% confluence was achieved. The medium was
replaced with adipogenic medium (DMEM-high glucose, 10% FBS, 10 μg/mL insulin, 0.5 mM
dexamethasone (Sigma-Aldrich, St. Louis, MO, USA), and 0.1 mM indomethacin (SigmaAldrich, St. Louis, MO, USA) and the cells were cultured for an additional 7 days. Cells were
treated every day with either media alone, fructose, ouabain (concentrations 1 nM, 10 nM, 25
nM, 100 nM, 250 nM, 500 nM, or 1000 nM) or 700 nM pNaKtide (previously described by
Sodhi et. al (Sodhi et al., 2015)). After 7 days, the cells were stained with Oil Red O solution to
analyze adipogenesis as previously described by Sodhi et al (Sodhi et al., 2015; Sodhi et al.,
2014). Media was collected for cytokine measurements, and cells were also collected from 75
cm2 flasks for western blot
Lentivirus Construction
Lentiviral constructs with NaKtide driven by an adiponectin promoter were constructed
by VectorBuilder Inc. and were used to achieve NaKtide expression. Lentiviral constructs
featured the adiponectin promoter driving expression of the NaKtide cassette linked by means of
a 2A peptide to eGFP for bicistronic expression.
The NaKtide sequence used for this vector
was ATGAGCGCCACCTGGCTGGCCCTGAGCAGGATCGCCGGTCTTTGCAACAGGGCC
GTGTTCCAG. Lentivirus with NaKtide and its counterpart Lenti-GFP (driven by adiponectin
promoter) were mixed into DMEM (10 uL/mL) with polybrene (100 uL/mL) and added to
approximately 60% confluent 3T3 L1 cells. After 24 hours, cells were placed in adipogenic
media and left for 14 days. After 14 days, cells were stained with Oil Red O solution to analyze
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adipogenesis. Media was collected for cytokine measurements, and cells were also collected
from 75 cm2 flasks for western blot analysis.
LDH Assay
Potential toxicity of ouabain was measured using a Pierce LDH Cytotoxicity Assay Kit
according to manufacturer instructions (ThermoFisher Scientific, Waltham, MA). Briefly, at the
end of treatment, 50 μl of medium solution was transferred to a 96-well plate and the LDH
reaction was performed. To determine LDH activity, the absorbance at 680 nm (background
signal) was subtracted from the absorbance at 490 nm. LDH activity was converted to
percentages compared to the maximum LDH activity control and the spontaneous LDH activity
control using the following formula:

%Cytoxicity =

Compound treated LDH activity − Spontaneous LDH activity
X100
Maximum LDH activity − Spontaneous LDH activity

Cytokine Measurements
TNFα, IL-6, and MCP-1 were measured in cell culture media using an ELISA assay kit
according to manufacturer instructions (Abcam Cambridge, MA) as reported previously
(Bartlett, Miller, Thiesfeldt, Lakhani, Khanal, et al., 2018; Sodhi et al., 2015).
Western Blot Analysis
Cell culture lysates were processed using TGH buffer. Homogenates were centrifuged,
the supernatant was isolated, and immunoblotting performed. Lysates were used for
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determination of α1 subunit of the Na/K-ATPase, FAS, PPARγ, MEST as previously reported
(Haller et al., 2012; Yan et al., 2013). Loading conditions were controlled for using GAPDH.
Measurement of c-Src phosphorylation
Cell culture lysates were processed using TGH buffer. Activation of c-Src was
determined as described previously (Yan et al., 2013). Polyclonal anti-Src [pY418] phosphospecific antibody was from Invitrogen (Camarillo, CA). Monoclonal antibody against total c-Src
was from Santa Cruz (Santa Cruz, CA). After immunoblotting for phospho-Src, the same
membrane was stripped and blotted for total c-Src. Activation of c-Src was expressed as the ratio
of phospho-Src/c-Src with measurements normalized to 1 for control samples.
Assessment of protein carbonylation
Cell culture lysates were processed using TGH buffer and western blotting for protein
carbonylation assay was done as previously described (Yan et al., 2013). 2, 4dinitrophenylhydrazine (DNPH) and antibody against 2, 4-dinitrophenyl (DNP) hydrazone
derivatives were purchased from Sigma-Aldrich. The signal density values of control samples
were normalized to 1 with Coomassie blue staining.

Transduction Efficiency
Transduction efficiency in lentivirus treated cells was performed using GFP images and
brightfield images. 7 days after transfection cells were checked for GFP expression using a
Nikon Eclipse 80i microscope equipped with a Nikon camera head DS-Fi1 (Nikon, Japan).
Brightfield and GFP images were merged and counted using Image J. Images were changed to 8
bit, enhanced through Threshold, Dilate, and Watershed functions, converted to mask using the
binary function, and enhanced. Black and white images were compared to the original image to
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ensure accurate representation of cells. The total number of cells was calculated from the
brightfield image, and the fluorescent cells were counted from the GFP image. This was
consistent and used for all subsequent images. The ratio of cells was calculated (brightfield/GFP)
and converted to a percentage.
Statistical analyses
Statistical significance between experimental groups was determined by the Tukey
method of analysis of multiple comparisons (P < 0.05). For comparisons among treatment
groups, the null hypothesis was tested by a one way analysis of variance (ANOVA). Data are
presented as means ± SE.
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Abstract
Obesity has become a worldwide epidemic. We have previously reported that systemic
administration of pNaKtide which targets the Na/K-ATPase oxidant amplification loop (NKAL)
was able to decrease systemic oxidative stress and adiposity in mice fed a high fat and fructose
supplemented western diet (WD). As adipocytes are believed to play a central role in the
development of obesity and its related comorbidities, we examined whether lentiviral-mediated
adipocyte-specific expression of NaKtide, a peptide derived from the N domain of the α1 Na/KATPase subunit, could ameliorate the effects of the WD. C57BL6 mice were fed a WD, which
activated Na/K-ATPase signaling in the adipocytes and induced an obese phenotype and caused
an increase in plasma levels of leptin, IL-6 and TNFα. WD also decreased locomotor activity,
expression of the D2 receptor and tyrosine hydroxylase in brain tissue, while markers of
neurodegeneration and neuronal apoptosis were increased following the WD. Selective adipocyte
expression of NaKtide in these mice fed a WD attenuated all of these changes including the brain
biochemical alterations and behavioral adaptations. These data suggest that adipocyte derived
cytokines play an essential role in the development of obesity induced by a WD and that
targeting the adipocyte NKAL loop may serve as an effective therapeutic strategy.
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Main Text
Obesity is a major international health challenge as it is often associated with other
comorbidities including (but not limited to) metabolic syndrome, cardiovascular diseases, chronic
kidney disease, non-alcoholic steatohepatitis (NASH), and neurodegenerative disorders
(Pugazhenthi, Qin, & Reddy, 2017; Sodhi et al., 2015; Sodhi et al., 2018; Sodhi et al., 2017). It is
estimated that by the year 2030, 38% of the world’s adult population will be overweight and 20%
will be obese (Hruby & Hu, 2015). Although traditionally the adipocyte had been thought to play
a passive role in the process of obesity, recent studies have established adipocyte malfunction as
playing a causative role in the pathogenesis of obesity, associated systemic oxidant stress and the
comorbidities of obesity including insulin resistance, accelerated cardiovascular disease and
NASH [2-4]. Evidence suggests that deranged mitochondrial function and chronic inflammation
in the adipocytes further contribute towards the pathogenesis of obesity (Cui, Kong, & Zhang,
2012; Oberg et al., 2004) .
Our group has demonstrated that the Na/K-ATPase functions as a scaffolding protein,
affecting a signal cascade that also serves to amplify oxidants in a feed forward manner (Aperia,
2007; Bagrov & Shapiro, 2008; Bagrov et al., 2009; Z. Li & Xie, 2009; Liang, Cai, Tian, Qu, &
Xie, 2006; J. Liu & Xie, 2010; Pierre & Xie, 2006; Tian et al., 2006; Z. Xie & Askari, 2002; Z.
Xie & Cai, 2003; Z. Xie & Xie, 2005). Activated Na/K-ATPase signaling has been demonstrated
in adipose, hepatic, renal, and cardiac tissues, thus implying a role for Na/K-ATPase signaling in
various disease models (J. Liu et al., 2016; Sodhi et al., 2015; Sodhi et al., 2018; Sodhi et al.,
2017). Specifically, we have demonstrated that reactive oxygen species (ROS) can both activate
this Na/K-ATPase signal cascade as well as generate additional ROS through downstream
consequences of this pathway (Y. Wang et al., 2014; Yan et al., 2013). NaKtide, a specific
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peptide antagonist of Src kinase, was derived from the α1 subunit of the NaK-ATPase, consisting
of Ser 415 to Gln 434. NaKtide or a cell permeant derivative, pNaKtide which was created by
merging NaKtide with a 13 amino acid TAT leading sequence, prevents the activation of Src
which is normally regulated by the α1 subunit of the Na/K-ATPase (Z. Li et al., 2009; J. Liu et
al., 2016). Since we have demonstrated that systemic administration of pNaKtide was able to
reduce oxidative stress, obesity and atherosclerosis induced by a western diet composed of high
fat and supplemental fructose (J. Liu et al., 2016; Sodhi et al., 2015; Sodhi et al., 2017), we were
interested in using this molecular strategy to examine the specific tissues involved in the
pathogenesis of obesity.
Lentiviral vectors have evolved over the last decade as a promising approach to target a
gene of interest using a promoter for a specific cell type (Cao, Sodhi, Inoue, et al., 2011).
Utilization of the lentiviral vector has been safe and highly effective in experimental models
(Ames & Lu, 2009; Bian et al., 2013; Cao, Sodhi, Inoue, et al., 2011; Eerola et al., 2013; W. Wu
et al., 2018). We therefore chose this strategy to test the hypothesis that adipocyte oxidant stress
caused by activation of adipocyte Na/K-ATPase signaling might play a central role in the
development and maintenance of obesity and its associated comorbidities.
Results
Effect of lenti-adiponectin-GFP-NaKtide on adiposity, metabolic balance, and locomotion
in C57BL6 mice fed a WD
The effectiveness and specificity of the NaKtide lentiviral-construct were evaluated by
immunofluorescence studies in C57BL6 mice fed a WD. Since adiponectin is expressed
specifically in adipocytes, the lentiviral construct with NaKtide driven by an adiponectin
promoter was used to achieve NaKtide expression specifically in adipocytes (Figure 30). Results
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showed that NaKtide expression was exclusively present in the adipose tissue and not visibly
expressed in liver and brain tissues (Figure 31). Further, our results showed that mice fed a WD
exhibited a significant increase in body weight over a period of 12 weeks compared to the mice
on normal chow (Figure 25A). The increase in the body weight was significantly attenuated by
the transduction of lenti-adiponectin-GFP-NaKtide (Figure 25A). Our results also demonstrated
a significant increase in the visceral and subcutaneous fat, liver weight, and heart weight in the
mice fed a WD, which was markedly reduced with lenti-adiponectin-GFP-NaKtide treatment
(Table 1). Food intake and energy intake did not differ amongst the different experimental
groups (Figure 25B and C). Energy expenditure was determined as heat production rate in units
of kcal/kg/day (Sodhi et al., 2017). The results showed significant reduction in the energy
expenditure of mice fed a WD compared to control group; this energy expenditure was
significantly increased with lenti-adiponectin-GFP-NaKtide treatment (Figure 25D). Further, our
results showed that oxygen consumption in mice fed a WD alone (2491±149 mL/kg/hr) was
significantly (p<0.01) decreased as compared to control (3104±88 mL/kg/hr). Treatment with
lenti-adiponectin-GFP-NaKtide (3146±232 mL/kg/hr) significantly (p<0.01) improved the
oxygen consumption as compared to WD alone. Since obesity has been associated with
decreased locomotion (Massiera et al., 2001; Sodhi et al., 2017), we further looked at the effect
of lenti-adiponectin-GFP-NaKtide on movement. Locomotor activity was measured as
previously described (Sodhi et al., 2017). Mice fed a WD showed decreased locomotion, and this
was normalized by treatment with the lenti-adiponectin-GFP-NaKtide (Figure 25E).
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Figure 25. Effect of lenti-adiponectin-GFP-NaKtide on adiposity, metabolic
balance, and locomotion in C57BL6 mice fed a WD.
Body weight (A). Food intake (B) Energy intake (C) Energy expenditure (D), and
Locomotion (E) determined via CLAMS cages after 48 hours. Data are displayed as
”scatter plots” showing data points and “box plots” showing the distribution of a
continuous variable as described in the Methods section. N=12-14/group; *p<0.05 vs.
#
##
Control (CTR), **p<0.01 vs. CTR, p<0.05 vs. Western Diet (WD), p<0.01 vs. WD.
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Table 1
Results are means ± SEM, n = 13-18/group. *p < 0.05, **p < 0.01 vs. control; #<0.05, ##
p < 0.01 vs WD
Effect of lenti-adiponectin-GFP-NaKtide on adipocyte phenotype and systemic
inflammatory profile in C57BL6 mice fed a WD
The WD altered the morphological phenotype of visceral adipocytes with dramatic
increases in the size and fat content of these cells. Mice treated with the lenti-adiponectin-GFPNaKtide showed an improved adipocyte phenotype as evidenced by significantly increased
numbers of adipocyte, but significant decreases in adipocyte cell area, when compared to mice
fed a WD alone (Figure 26A, B & C). Mice injected with lenti-adiponectin-GFP-NaKtide and
fed the normal chow diet showed no significant differences in any of the aforementioned
measurements from the control mice. There was also no significant difference noted between
mice injected with the empty vector control, the lenti-adiponectin-GFP lacking the NaKtide
sequence that were fed a WD when compared to mice fed a WD alone. We next evaluated the
markers directly tied to the altered adipocyte phenotype that plays a causal role in the

85

aggravation of systemic oxidative stress. Our Western blot analysis showed the upregulated
expression of lipogenic marker, fatty acid synthase (FAS) and adipogenic markers, peroxisome
proliferator-activated receptor gamma (PPARγ) and mesoderm specific transcript gene (MEST)
in WD fed mice. This upregulation was significantly attenuated in lenti-adiponectin-GFPNaKtide transduced mice (Figure 26D-F). Since adipose mitochondria participate in energy
expenditure, we measured genes of mitochondrial biogenesis in adipose tissue. Our results
showed a significant down regulated expression of peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC-1α), a major regulator of mitochondrial biogenesis, in mice fed
a WD, as compared to control. This down regulation was prevented by lenti-adiponectin-GFPNaKtide treatment (Figure 26G). Similarly, the expression of genes related to mitochondrial
biogenesis and the “browning” phenomenon of adipose tissue, including expression of mitofusin
(MFN) 1 and 2, and sirtuin 3 (Sirt3) were significantly down regulated in mice fed a WD.
Importantly, the expression of the aforementioned genes were all significantly increased upon
treatment with lenti-adiponectin-GFP-NaKtide (Table 1). Further, our results showed that the
expression level of the inflammatory cytokine, tumor necrosis factor alpha (TNFα), was
significantly attenuated by treatment with lenti-adiponectin-GFP-NaKtide (Table 1). Leptin, a
hormone secreted by adipocytes, is a potent inducer of ROS generation by promoting
inflammation and oxidative stress (Dubey & Hesong, 2006; Fernandez-Sanchez et al., 2011).
Mice fed a WD exhibited upregulated levels of
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leptin, as compared to control. This was significantly attenuated by lenti-adiponectin-GFPNaKtide treatment (Table 1).

87

Figure 26. Effect of lenti-adiponectin-GFP-NaKtide on adipocyte phenotype,
mitochondrial biogenesis, inflammatory markers, and Na/K-ATPase signaling
cascade in C57BL6 mice fed a WD.
Representative H&E staining in visceral adipose tissue. Images taken with 20x
objective lens; scale bar represents 100 µm (A). Quantitative analysis of the
adipocyte number (B) and adipocyte area (C) in visceral adipose tissue. Western blot
analysis of visceral adipose tissue homogenates, with data shown as mean band
density normalized to GAPDH, for fatty acid synthase (FAS) (D), peroxisome
proliferator-activated receptor gamma (PPARγ) (E), mesoderm specific transcript
(MEST) (F) and peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC1α) (G). Quantitative analysis of protein carbonylation levels (shown as
2, 4-dinitrophenylhydrazine (DNP) expression) with Coomassie staining as a
loading control (H). Immunoblot analysis of α-1 subunit (I) and α-2 subunit (J) with
data shown as mean band density normalized to GAPDH. pSrc immunoblot analysis
with data shown as mean band density normalized to total Src (K). All gels have
been cropped above and below the band, and the full blots have been included in
Supplementary Figure S5 D-K. N=12-14/group; *p<0.05 vs. CTR, **p<0.01 vs.
#
##
CTR, p<0.05 vs. WD, p<0.01 vs. WD.

The insulin resistance in mice fed a WD was reversed by treatment with lentiadiponectin-GFP-NaKtide (Figure 27A). Inflammatory cytokines are both indicative of high
levels of oxidative stress as well as contribute to the production of oxidants (Sodhi et al., 2015).
Mice fed a WD showed significantly upregulated plasma levels of the inflammatory cytokines
TNFα, monocyte chemoattractant protein-1 (MCP-1), and interleukin-6 (IL-6) (Figure 27B-D).
Treatment with the lenti-adiponectin-GFP-NaKtide ameliorated the increases in the plasma
concentrations of these inflammatory cytokines. Our results showed increases in plasma leptin
concentrations in mice fed a WD. This was attenuated by treatment with lenti-adiponectin-GFPNaKtide (Figure 27E).
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Figure 27. Effect of lenti-adiponectin-GFP-NaKtide on systemic inflammatory
cytokines, and metabolic profile in C57BL6 mice fed a WD. Glucose tolerance test (A),
Plasma levels of TNFα (B), monocyte chemoattractant protein-1 (MCP-1) (C) interleukin-6
(IL-6) (D) and leptin (E) assessed by ELISA assay. N=12-14/group; *p<0.05 vs. CTR,
#
##
**p<0.01 vs. CTR, p<0.05 vs. WD, p<0.01 vs. WD.

Effect of lenti-adiponectin-GFP-NaKtide on Na/K-ATPase/Src signaling cascade in
C57BL6 mice fed a WD
Protein carbonylation is an established method for assessing oxidative stress (Bartlett,
Miller, Thiesfeldt, Lakhani, Shapiro, et al., 2018; Dalle-Donne, Rossi, Giustarini, Milzani, &
Colombo, 2003). Our results showed a significant increase in protein carbonylation, measured by
2, 4-dinitrophenylhydrazine (DNP), in mice fed a WD which was attenuated by treatment with
the lenti-adiponectin-GFP-NaKtide (Figure 26H). Expression of the α1 subunit of the Na/KATPase was significantly down regulated in visceral fat of mice fed a WD. This was prevented
by lenti-adiponectin-GFP-NaKtide treatment (Figure 26I). Conversely, the up-regulated
expression of the α2 subunit in mice fed a WD was significantly attenuated by lenti-adiponectin-
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GFP-NaKtide (Figure 26J). Treatment with lenti-adiponectin-GFP-NaKtide also prevented Src
activation in mice fed a WD (Figure 26K).
Effect of lenti-adiponectin-GFP-NaKtide on neurodegeneration in C57BL6 mice fed a WD
Obesity and systemic oxidative stress have been implicated with neurodegenerative
disorders, so we next examined the effect of lenti-adiponectin-GFP-NaKtide on these
parameters. Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the production of
dopamine; the expression of both TH and the type 2 dopamine receptor (D2) correlate with
locomotor activity (Mundorf, Joseph, Austin, Caron, & Wightman, 2001). TH staining showed
decreased expression of TH in the prefrontal cortex of the brain in mice fed a WD; western blot
analysis of TH showed significant decrease in brains of mice fed WD (Figure 28A and B).
Treatment with lenti-adiponectin-GFP-NaKtide negated these changes. Furthermore, expression
of D2 receptor in the brain was significantly down regulated in mice fed a WD. This was also
improved by the treatment with the lenti-adiponectin-GFP-NaKtide (Figure 28B). Further, our
results demonstrated an increase in protein carbonylation in the brain tissues of mice fed a WD;
this was attenuated by the lenti-adiponectin-GFP-NaKtide (Figure 28C). Our results also showed
decreased expression of postsynaptic density protein 95 (PSD95), a marker of synaptic plasticity
(Kothari et al., 2017) in the brain tissues of WD mice. Treatment with lenti-adiponectin-GFPNaKtide improved this PSD95 expression (Figure 28D). Tau, a marker of tangled neuron tracks
and a hallmark of neurodegenerative disease (Kothari et al., 2017), was up regulated in the brains
of mice fed WD and markedly reduced by the lenti-adiponectin-GFP-NaKtide (Figure 28E). The
TUNEL assay demonstrated that apoptosis was increased in the brain tissue of mice fed WD.
Apoptosis was also attenuated by the lenti-adiponectin-GFP-NaKtide treatment (28F-G).
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Figure 28. Effect of lenti-adiponectin-GFP-NaKtide on neurodegeneration in brain
tissue in C57BL6 mice fed a WD.
Representative and quantitative analysis based on tyrosine hydroxylase staining (A),
images taken with 20X objective lens; scale represents 100 µm. Immunoblot analysis for
tyrosine hydroxylase (TH) (B). Protein carbonylation levels with Coomassie staining as a
loading control (C). Immunoblot analysis of D2 receptor with data shown as mean band
density normalized to GAPDH (D). Immunoblot analysis for marker of synaptic plasticity,
PSD95 (E), and marker of tangles in neuron tracks, Tau (F). Representative images and
quantification of the TUNEL assay in brain tissue (G-H). All gels have been cropped
above and below the band, and the full blots have been included in Supplementary Figure
#
##
S6 B-F. N=12-14/group; *p<0.05 vs. CTR, **p<0.01 vs. CTR, p<0.05 vs. WD, p<0.01
vs. WD.

Effect of lenti-adiponectin-GFP-NaKtide on hepatic histology, inflammation, and fibrosis
in C57BL6 mice fed a WD
Next, we aimed to determine whether NaKtide targeted specifically to adipocytes was
able to attenuate the development of nonalcoholic steatohepatitis (NASH). H&E staining of liver
sections from C57BL6 mice fed a WD showed inflammation and increased lipid accumulation in
the liver as compared to the control group (Figure 32A). Treatment with lenti-adiponectin-GFPNaKtide exhibited decreased lipid and inflammatory cell infiltration. We note that the viral
transduction did not lead to demonstrable hepatic NaKtide expression (Figure 31) implying an
indirect effect. Mice fed a WD had significantly increased lipid accumulation in the liver
compared to mice fed a normal chow diet as demonstrated by Oil Red O staining. Administration
of lenti-adiponectin-GFP-NaKtide decreased lipid accumulation in mice fed a WD (Figure 32B).
CD36, a fatty acid transport protein, contributes to the progression of NASH (Sodhi et al., 2017).
Our results showed that CD36 mRNA expression was decreased by lenti-adiponectin-GFPNaKtide treatment as compared to the mice fed a WD (Figure 32C). Similarly, TNFα and F4/80
mRNA expression, markers of inflammation and macrophage/kupffer cells infiltration, were also
increased in mice fed a WD as compared to control mice (Figure 32D-E). These changes were
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attenuated by the lenti-adiponectin-GFP-NaKtide treatment. Furthermore, mRNA expression of
hepatic matrix metalloproteinases (MMP) 2 and 9, genes related to fibrogenesis, were also
elevated in mice fed a WD, and these increases were also attenuated with lenti-adiponectin-GFPNaKtide treatment (Figure 32F-G). These findings indicate that the lenti-adiponectin-GFPNaKtide not only improves the metabolic profile in adipocytes, but also has profound effects on
the liver through indirect mechanisms.
Correlational analysis of markers associated with reprogramming of adipocyte phenotype,
NASH and neurodegeneration in C57BL6 mice fed a WD
First, we examined the degree of correlation between the various measurements
performed in our study. These data are summarized in Figure 29A. Our results showed a number
of strong correlations. In particular, it was clear that the plasma levels of inflammatory cytokines
correlated with locomotor activity (Figure 29A). When we performed multiple linear regression
analysis, it was clear that a model consisting of plasma TNFα and IL-6 predicted the locomotor
activity with excellent accuracy (R2=0.84) (Figure 29B). We have also included a webpage
illustrating heat map and corresponding box plates as Figure 33.
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Figure 29. Correlational analysis of the markers associated with reprogramming of
adipocyte phenotype in C57BL6 mice fed a WD.
Correlational analysis of the markers associated with reprogramming of adipocyte phenotype
in C57BL6 mice fed a WD using the R package Psycho software (A). Multiple linear
regression analysis between the plasma inflammatory cytokines, IL-6 and TNF-α, predicting
the locomotor activity (B).
Discussion
In this study, we targeted the Na/K-ATPase signaling antagonist NaKtide specifically to
adipocytes in mice fed a WD using a lentivirus employing adiponectin to drive its expression,
thus expressing the NaKtide only in adipocytes. In our previous studies, systemic pNaKtide
treatment attenuated obesity, as well as aging, NASH, and atherosclerosis (Sodhi et al., 2015;
Sodhi et al., 2018; Sodhi et al., 2017). In this study, our results showed that targeting of NaKtide
specifically to adipocytes was still able to reverse WD-induced changes in metabolic profile,
oxidative stress, and inflammation. This highlights the importance of the Na/K-ATPase oxidant
amplification loop within the adipocyte as well as the importance of adipocyte biology itself.
There is accumulating evidence suggesting that adipocyte mitochondria might play an important
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role in the development of dysfunctional adipocytes (Boudina & Graham, 2014). Our results
showed that PGC1α levels, the master regulator of mitochondrial biogenesis and adaptive
thermogenesis (Villena, 2015), increased upon adipocyte-targeted NaKtide expression.
Furthermore, the expression of genes associated with mitochondrial biogenesis and “browning”
of fat, including MFN1, MFN2, and SIRT1, were increased by NaKtide treatment. Adipocytes
also showed increased protein carbonylation in mice fed a WD. This was decreased by NaKtide
treatment, indicating a reduction in oxidative stress within the adipose tissue.
Our results also showed that expression of the α1 subunit of the Na/K-ATPase was
significantly downregulated in visceral fat by the WD. We have shown previously that oxidative
stress can induce endocytosis of α1; we therefore propose that WD increases oxidative stress,
increasing α1 endocytosis (H. Cai et al., 2008; J. Liu et al., 2004; Yan et al., 2016). Some of the
endocytosed α1 is recycled to the surface, while some is destroyed through endosomal and
proteolytic pathways. Previous evidence has shown that ROS can accelerate the degradation of
the Na/K-ATPase (W. H. Huang et al., 1992; W. H. Huang, Y. Wang, A. Askari, N. Zolotarjova,
& M. Ganjeizadeh, 1994; Kim & Akera, 1987; J. Liu et al., 2012; Thevenod & Friedmann,
1999). Hence, we propose that increased oxidative stress induced by WD leads to a decrease in
total adipocyte α1 expression in mice fed a WD. Interestingly, expression of α2 subunit of Na/KATPase was noted to move in the opposite direction as α1; this may be related to a compensatory
mechanism that has yet to be elucidated. Treatment with pNaKtide also blocked Na/K-ATPaseregulated Src activation in mice fed a WD.
Studies in mouse models of obesity have shown that increased systemic oxidative stress
is due to an altered adipocyte phenotype (Furukawa et al., 2004; Le Lay et al., 2014).
Comorbidities such as insulin resistance and dyslipidemia also contribute to systemic oxidative
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stress (Vincent & Taylor, 2006). Attenuation of the NKAL in the adipocytes during exposure to
the WD ameliorated oxidant stress within these cells as well as the WD-induced hypertension,
dyslipidemia, and insulin resistance. In particular, the increases in plasma levels of leptin and
inflammatory cytokines (i.e., IL-6, TNFα, and MCP-1) in mice fed a WD were dramatically
attenuated by NaKtide expression in adipocytes. This suggests a central role of the Na/K-ATPase
signaling loop within adipocytes in the development of obesity and systemic oxidative stress in
response to a WD.
Perhaps of greater interest, we observed profound changes in the locomotor activity of
animals with the switch to a WD, which were dramatically attenuated by adipocyte NaKtide
treatment. Specifically, animals given the WD demonstrated marked reductions in activity level
and calculated energy expenditure. Such changes were also observed in previous reports, even in
a mouse strain which did not gain excessive amounts of weight (Sodhi et al., 2017). Previously,
we found that systemic pNaKtide prevented these decreases in activity, and we found that
NaKtide expression limited to the adipocytes accomplished the same effect. We found that these
behavioral changes were strongly associated with changes in brain D2 receptor expression and
tyrosine hydroxylase expression, confirmed through both immunofluorescence and western blot.
All of these changes appeared to be linked to adipocyte cytokine production. In fact, mouse
activity could be predicted with a linear combination of plasma TNFα and IL-6 levels with an R2
of 84%. In addition to these functional effects, marked changes in brain biochemistry and
morphology were also noted with the western diet, and again, adipocyte NaKtide treatment
ameliorated these, which included protein carbonylation, expression of PSD95 and pTau as well
as neuronal apoptosis. The implications of these observations to cognitive and emotional
disturbances associated with obesity and other neurodegenerative disorders including aging
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related cognitive impairment have yet to be explored. We also note that virtually all
consequences of obesity such as dyslipidemia, insulin resistance and NASH were also attenuated
by adipocyte NaKtide expression.
Together, our results suggest a central role for the Na/K-ATPase oxidant amplification
loop within adipocytes in the pathogenesis of obesity induced by a WD as well as the commonly
associated comorbidities. Somewhat surprisingly, behavioral changes could be attributed to this
deranged adipocyte metabolism which, in turn, were very strongly associated with the levels of
cytokines known to be produced by adipocytes. As we review these data, it appears not only that
targeting the Na/K-ATPase oxidant amplification loop may be promising in terms of efficacy as
well as limiting off-target effects. If these findings can be confirmed in humans, a number of
therapeutic strategies might be envisioned ranging from surgical control of fat mass, molecular
biological strategies described in this report to simple dietary manipulations.
Materials and Methods
Experimental Design
All animal studies were approved by the Marshall University Animal Care and Use
Committee in accordance with the National Institutes of Health (NIH) Guide for Care and Use of
Laboratory Animals. C57BL6 mice (Male, 8 weeks) were purchased from Hilltop Lab Animals.
After arriving to the Robert C. Byrd Biotechnology Science Center Animal Resource Facility
(ARF) mice were placed in cages, and fed normal chow diet with ad libitum access to water.
Animals were randomly divided into five groups (12-18/group) as follows: 1. Control (normal
chow) 2. NaKtide (normal chow+ lenti-adipo-GFP-NaKtide) 3. Western Diet (WD) 4. WD+GFP
(WD+lenti-adiponectin-GFP) 5. WD+NaKtide (WD + lenti-adiponectin-GFP-NaKtide). Western
diet (WD) containing fructose is a well-known inducer of diet-induced obesity (Andre et al.,
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2014; Cao et al., 2012; Sodhi et al., 2015). WD was purchased commercially from Envigo
(Indianapolis, IN), and contained 42% fat, 42.7% carbohydrate, and 15.2% protein, yielding 4.5
KJ/g specific energy. Fructose was purchased commercially from Alfa Aesar (Ward Hill, MA).
Fructose water was made at a concentration of 42g/L, yielding 0.168 KJ/mL of specific energy.
Mice in the WD group were given WD and ad libitum access to fructose water.
Lentiviral construct with NaKtide driven by an adiponectin promoter were constructed by
VectorBuilder Inc. and were used in mice to achieve NaKtide expression specifically in adipose
tissue (Figure S2). Lentiviral construct featured the adiponectin promoter driving expression of
the NaKtide cassette linked by means of a 2A peptide to eGFP for bicistronic expression. The
NaKtide sequence used for this vector
was ATGAGCGCCACCTGGCTGGCCCTGAGCAGGATCGCCGGTCTTTGCAACAGGGCC
GTGTTCCAG. Lentivirus (100 uL, 2X109 TU/mL in saline) with NaKtide and its counterpart
Lenti-GFP (driven by adiponectin promoter) were injected into mice intraperitoneally (IP) at
week 0. Groups 2 and 5 received an injection of lenti-adiponectin-GFP-NaKtide, and group 4
was given an injection of lenti-adiponectin-GFP. Body weight was measured weekly for 12
weeks, as well as food and water intake. At the time of sacrifice, the body weight, visceral and
subcutaneous fat weight, liver weight, heart weight, kidney weights, and brain weights were
measured. Blood samples were collected for determination of leptin and inflammatory cytokine
levels. Tissues were flash frozen in liquid nitrogen and maintained at -80°C, preserved in OCT
for sectioning, or placed in paraformaldehyde for paraffin embedding.
Indirect calorimetry and locomotor activity
At the end of the 12-week period, energy expenditure, oxygen consumption, and
locomotor activity were measured as described previously (Sodhi et al., 2017). All mice were
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acclimatized to the cages for 24 hours prior to an additional 48 hours of recordings under the
regular 12- hour light/dark cycle.
Glucose Tolerance Test
At the end of the 12-week period, mice were fasted for 8 hours. After the fasting period, a
10% glucose solution (2g/kg body weight) was injected intraperitoneally. Samples were taken
from the tail vein at 0, 30, 60, 90, and 120 minutes after glucose injection. Blood glucose was
measured using the Accutrend Sensor glucometer.
Cytokine and Leptin Measurements
Plasma TNFα, IL-6, MCP-1, leptin were measured using an ELISA assay kit according to
manufacturer instructions (Abcam Cambridge, MA) as reported previously (Sodhi et al., 2017).
RNA extraction and real time PCR
Total RNA was extracted from adipose and hepatic tissue using RNeasy Protect Mini Kit
(QIAGEN, Maryland) as described previously(Sodhi et al., 2018). Total RNA was analyzed by a
quantitative real time polymerase chain reaction. Real time PCR was done using SYBR Green
PCR Master Mix on a 7500 HT Fast Real-Time PCR System (Applied Biosystems, US). Each
reaction was done in triplicate. All experimental samples were normalized using GAPDH.
Specific primers were used for MFN 1 and 2, Sirt3, TNFα, Leptin, CD36, MMP2 and 9 and
F4/80.
Western Blot Analysis
Visceral adipose tissue and brain tissue were pulverized with liquid nitrogen and placed
in RIPA homogenization buffer. Homogenates were centrifuged, the supernatant was isolated,
and immunoblotting performed. Adipose tissue was used for determination of α1/2 subunits of
the Na/K-ATPase, FAS, PPARγ, MEST, and PGC1α as previously reported (Haller et al., 2012;
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Yan et al., 2013). Brain tissue was used for expression of tyrosine hydroxylase (TH), dopamine 2
(D2) receptors, PSD95, p-Tau, and Tau expression. D2 receptor antibody and tyrosine
hydroxylase was from Abcam (Cambridge, MA) and PSD95, p-Tau, and Tau from Cell
Signaling (Danvers, MA).
Measurement of c-Src phosphorylation
Whole cell lysates from visceral adipose tissue were prepared with RIPA buffer.
Activation of c-Src was determined as described previously (Yan et al., 2013). Polyclonal antiSrc [pY418] phospho-specific antibody was from Invitrogen (Camarillo, CA). Monoclonal
antibody against total c-Src was from Santa Cruz (Santa Cruz, CA). After immunoblotting for
phospho-Src, the same membrane was stripped and blotted for total c-Src. Activation of c-Src
was expressed as the ratio of phospho-Src/c-Src with measurements normalized to 1 for control
samples.
Assessment of protein carbonylation
Whole cell lysates from visceral adipose tissue and brain tissue were prepared with RIPA
buffer and western blotting for protein carbonylation assay was done as previously described
(Yan et al., 2013). 2, 4-dinitrophenylhydrazine (DNPH) and antibody against 2, 4-dinitrophenyl
(DNP) hydrazone derivatives were purchased from Sigma-Aldrich. The signal density values of
control samples were normalized to 1 with Coomassie blue staining.
Immunofluorescence studies in adipose, hepatic, and brain tissues
Adipose tissue, hepatic tissue, and brain tissue were frozen in OCT compound, cut into 6
um sections and mounted on slides. The sections were fixed with 4% PFA for 15 minutes,
washed once with PBS, probed with 1:100 primary antibody dilution and 1:1000 secondary
antibody (Alexa 455 Red), and then mounted with DAPI solution and coverslips. Expression of
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lenti-adiponectin-GFP was determined using a Nikon Eclipse 80i microscope equipped with a
Nikon camera head DS-Fi1 (Nikon, Japan). Expression of lenti-adiponectin-GFP-NaKtide was
determined using an RFP filter on Nikon Eclipse 80i microscope equipped with a Nikon camera
head DS-Fi1 (Nikon, Japan). Protocol was adapted from Alexa-fluor-555 Cell Analysis from
Thermo Fisher, and IHC protocols (IHC WORLD Life Science Products).
Hematoxylin and Eosin Staining
Visceral adipose tissue and hepatic tissue was cut into 6 µm sections and stained with
hematoxylin and eosin for histological analysis as previously described (Sodhi et al., 2018; Sodhi
et al., 2017). Adipocyte number and area was determined using ImageJ software (NIH) (Parlee,
Lentz, Mori, & MacDougald, 2014). In brief, H&E stained adipose tissue images (20X
magnification) were opened in ImageJ. Images were changed to 8 bit, enhanced through
Threshold, Dilate, and Watershed functions, converted to mask using the binary function, and
enhanced. Black and white images were compared to the original image to ensure accurate
representation of adipocytes. The total number and size of adipocytes was calculated using the
“analyze particles” command. To calculate the number of adipocytes, the size of the sample was
normalized based on the number of pixels present in the image and the magnification. This was
consistent and used for all subsequent images. The number of total adipocytes in the distribution
is calculated from this for scale.
Oil Red O Staining
Liver tissues, frozen in OCT compounds, were cut into 6 µm sections and Oil Red O
staining was done as described previously (Sodhi et al., 2017). Images were taken on a Nikon
Eclipse 80i microscope equipped with a Nikon camera head DS-Fi1 (Nikon, Japan). For
quantitative analysis, total area of the red pixels on stained tissue was measured by Image J
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software (NIH). The data was expressed as percentage of the Oil Red O stained area with suspect
to total area.
Tyrosine Hydroxylase Staining
Brain tissue preserved in paraffin was cut into 6µm sections and mounted on slides.
Deparaffinization, rehydration, and antigen retrieval were performed on the slides. After drying,
slides were stained with anti-Tyrosine Hydroxylase (Abcam, US) overnight, following modified
manufacturer protocol (Becker et al., 2018). Imaging was done with a Nikon camera head DSFi1 (Nikon, Japan). For quantitative analysis, total area of the green pixels on stained tissue was
measured by Image J software (NIH). The data was expressed as percentage of the green stained
area with respect to total area.
TUNEL assay for DNA damage detection
DNA double-strand breaks were detected in frozen mouse brain tissue using the ClickiT® Plus TUNEL Assay (Thermo Fisher Scientific Inc., US) according to the manufacturer’s
protocol. Specimens were mounted using VECTASHIELD® mounting medium and
counterstained with 50 mg/ml DAPI. Images were collected using a digital inverted microscope
that spanned the entire area of the tissues on the cover slip. The percentage of TUNEL-positive
cells was calculated based on the number of positively stained cells divided by the total number
of cells multiplied by 100 as reported previously (Sodhi et al., 2018).
Statistical analyses
The plots used were combination of scatter and boxplots. The boxplot displays the
distribution of the data. It visualizes five summary statistics (the median, two hinges and two
whiskers), and all "outlying" points individually (van Raalte & Egorov, 2015). The boxplot was
defined by:
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Notch lower = median - 1.58 * interquartile range (IQR) / sqrt (n) (A. Stolarczyk, Horvath,
Szczechura, Kaminska, & Dziechciarz)
Middle = median
Notch upper = median + 1.58 * IQR / sqrt (n);
Lower hinge is the 25th percentile
Upper hinge is the 75th percentile
Data were analyzed and presented with the statistical program R using the packages
ggplot2 and doBy. Multiple groups of parametric data (passed Shapiro-Wilk normality test) were
compared with one way analysis of variance (ANOVA) and individual group means compared
with an unpaired t-test employing the Holm correction for multiple comparisons. Nonparametric
data were analyzed with the Wilcoxon rank sum test, also employing the Holm correction for
multiple comparisons. All data comparisons are presented at the NS, p<0.05 and p<0.01 levels.
Correlation analysis was performed using the R package Psycho. The fit of a plane based on
TNFα and IL-6 to locomotion was performed using linear regression and displayed with the R
package plot3D.
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Supplementary Information

Figure 30. Lentiviral construct of lenti-adiponectin-GFP-NaKtide.
An adiponectin promoter drove expression of the NaKtide cassette linked
by means of a 2A peptide to eGFP for bicistronic expression.
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Figure 31. Immunofluorescence analysis of GFP and NaKtide in adipose, hepatic, and
brain sections from mice transduced with lenti-adiponectin-GFP and lentiadiponectin-GFP-NaKtide.
Representative images taken with 20X objective lens; scale represents 100 µm.
n=6/group.
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Figure 32. Effect of lenti-adiponectin-GFP-NaKtide on hepatic tissue in C57BL6
mice fed a WD.
Representative H&E staining of the liver tissue. Arrows mark indicative of increased lipid
accumulation and inflammation. (A) Lipid accumulation measured as the relative
absorbance of Oil Red O staining (B). Images taken with 40X objective lens, scale bar
represents 100 µm. qRT-PCR analysis of CD36 (C), TNFα (D), F4/80 (E), matrix
metalloproteinases (MMP) 2 (F), and MMP9 (G). N=12-14/group; *p<0.05 vs. CTR,
#
##
**p<0.01 vs. CTR, p<0.05 vs. WD, p<0.01 vs. WD.
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Figure S4: Webpage illustrating heat map and corresponding box plots.
https://public.tableau.com/profile/joseph.shapiro#!/vizhome/Sodhi_Rebecca_v2/Dashboard1?pu
blish=yes
Note: Data shown as heat map with data shown in scientific notation as well as boxplot showing
actual data points. Heat map has color-coding showing marked decreases or increases relative to
first column. This can be changed using dropdown filters in webpage.
Figure 33. Webpage illustrating heat map and corresponding box plots.
Data shown as heat map with data shown in scientific notation as well as
boxplot showing actual data points. Heat map has color-coding showing
marked decreases or increases relative to first column. This can be changed
using dropdown filters in webpage.
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Figure 34. Uncropped Western Blots for Figure 26.
Uncropped western blots for membranes shown in Figure 26
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Figure 35. Uncropped Western Blots for Figure 28.
Uncropped western blots for membranes shown in Figure 4.
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CHAPTER 6
DISCUSSION
Collectively, this work explores the hypothesis that specific NaKtide expression in
adipocytes modulates the adipocyte redox state which accomplishes two specific ends:
amelioration of both local oxidative stress (inside the adipose tissue itself) and systemic
inflammation and prevention of the dysfunctional adipocyte phenotype in both in vitro and in
vivo models of obesity.
As has been mentioned, obesity is a disease characterized by chronic inflammation.
Obesity not only increases oxidative stress, but it simultaneously decreases expression and
activity of key cytoprotective systems while increasing the inflammatory cytokines released by
adipocytes; obviously, obesity pushes the adipocyte towards a severely pro-inflammatory state
and causes the adipocyte to secrete proinflammatory adipokines and cytokines that are
detrimental on peripheral organs and tissues and can severely impact their function(Cao et al.,
2012). WD and high fat diet (HFD) specifically can induce metabolic inflammation in both
central and peripheral organs by this mechanism, which further contributes to the pathogenesis of
obesity(Gutierrez-Tenorio et al., 2017; Kothari et al., 2017). Consumption of these diets induces
immune cell responses and tissue inflammation in adipose tissue, which can also change the
secretory profile of the adipocytes (Naznin et al., 2018).
The data presented here supports the hypothesis that expression of NaKtide in adipocytes
would reduce adipogenesis and obesity by inhibiting the Na/K-ATPase-mediated oxidant
amplification loop. Previous work on the subject has extensively shown that the Na/K-ATPase
signaling is a regulator of oxidant amplification, and when the Na/K-ATPase is oxidized it forms
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an amplification loop that causes a sharp rise in the presence of ROS and consequently oxidative
stress (J. Liu et al., 2016; Rebecca D. Pratt et al., 2019; Sodhi et al., 2015; Sodhi et al., 2018;
Sodhi et al., 2017). The previously done work has not taken into account the specific power held
by adipocytes. For decades adipocyte biology has been a growing field, and it is believed that the
adipocyte plays a much larger role in metabolism and health than just being an energy reservoir
that are dysfunctional in obesity. It has been reported that adipose tissue is responsible for
secreting hormones, cytokines, and adipokines that can potentially negatively impact the redox
state of not only the adipocytes but other tissues as well(Lafontan, 2014; Okuno et al., 2018;
Victorio & Davel, 2019). Part of our hypothesis was that by reducing oxidative stress with
NaKtide treatment in the adipocytes would be able to reduce systemic oxidative stress; an
apparent reduction in oxidative stress has been shown, and it is believed that this change in redox
biology in the adipocytes is responsible for the amelioration of the obese phenotype and the
reduction in systemic oxidative stress.
Dysfunctional adipocytes are characterized by inflammation, altered adipokine secretion
and increased pro-inflammatory cytokine production (Goossens & Blaak, 2015); all these factors
were observed in our models and all of these factors were attenuated with either pNaKtide or
lenti-adiponectin-GFP-NaKtide treatment. This suggests that the Na/K-ATPase oxidant
amplification loop can indeed exacerbate the obese phenotype and further lead to adipocyte
dysfunction (Figures 14, 18, 19, and 20) as we saw this increase in dysfunction in our cells
treated with ouabain). By hindering this loop, we are able to reduce inflammation and adipocyte
dysfunction in our models (Figures 14, 18, 19, and 20).
A lentiviral vector delivered NaKtide in both our in vitro and in vivo models. By utilizing
a lentiviral vector, NaKtide was able to enter the cell. Our hypothesis involves specific targeting
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to adipocytes, so the use of the lentiviral vector was to ensure we had expression of NaKtide in
the adipocytes only, and the risk of exocytosis of NaKtide to neighboring tissues would be
prevented since NaKtide is cell membrane impermeable. This is confirmed in Figure 31;
immunofluorescence analysis for GFP and NaKtide in adipose tissue, liver tissue, and brain
tissue showed there was no expression of NaKtide outside the adipose tissue. Expression of lentiadiponectin-GFP-NaKtide showed a promising decrease in adipogenesis, and was used in a
rodent model of obesity to see if it has similar effects to systemic administration of
pNaKtide(Sodhi et al., 2015).
There is a strong link between obesity and metabolic imbalance, and oxidative stress has
been implicated with the chronic inflammatory state seen in obesity (Gutierrez et al., 2009;
Trayhurn, 2007; Wellen & Hotamisligil, 2003). Here, it has been demonstrated that
administration of pNaKtide effectively reduces adipogenesis in vitro by antagonizing specific
Na/K-ATPase–mediated amplification of ROS signaling (i.e. treatment with ouabain) (Figure
20). Our results with lenti-adiponectin-GFP-NaKtide, specifically targeted to the adipocytes
themselves, show a similar effect in vivo (Figure 26).
In 3T3-L1 cells, exposure to pNaKtide and transfection with lenti-adiponectin-GFPNaKtide decreased adipogenesis. pNaKtide treatment attenuated oxidative stress, decreased lipid
accumulation, and decreased expression of major adipogenic markers such as PPARγ, MEST,
and FAS. There was a significant upregulation of adiponectin level in the pNaKtide treated cells
as well. In cells treated with pNaKtide, inflammation was reduced and protein carbonylation was
decreased, indicating a decrease in oxidative stress and inflammation. These effects were seen
even when signaling was activated by ouabain.
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These observations are promising and offer novel information for Na/K-ATPase research
in adipocytes. By utilizing ouabain we have confirmed the role of the Na/K-ATPase oxidant
amplification loop in the process of adipogenesis. Combined with the activation of
transcriptional regulators of adipogenesis, activation of Na/K-ATPase signaling enhanced
adipogenesis and increased ROS generation. Our data shows a potentially larger role of the
Na/K-ATPase oxidant amplification loop in adipocyte biology and obesity pathology which we
further explored in vivo.
Based on our in vitro data, we applied lenti-adiponectin-GFP-NaKtide to a rodent model
of obesity. In this study, our results showed that targeting of NaKtide specifically to adipocytes
was able to prevent WD-induced changes related to metabolic profile, oxidative stress, and
inflammation, highlighting the importance of the Na/K-ATPase oxidant amplification loop
within the adipocyte. We report that the obesity phenotype, evidenced by significant weight gain,
increased fat deposits, and altered metabolic profile, was markedly improved with lentiadiponectin-GFP-NaKtide treatment, which we believe attenuated Na/K-ATPase oxidant
amplification in the adipocyte. Even though lenti-adiponectin-GFP-NaKtide was targeted
specifically to the adipocytes, we present several peripheral effects of our treatment (i.e.
decreases in NASH and neurodegeneration discussed in Chapter 5), which suggests adipocyte
phenotype has a larger role in obesity than previously recognized.
Treatment with pNaKtide in our in vitro model showed a hopeful therapeutic effect.
pNaKtide alone decreased adipogenesis, ROS, and the inflammatory profile of the adipogenic
cells, and was able to supersede the increases in inflammation and adipogenesis caused by
ouabain. This suggests that the effect of pNaKtide on adipogenesis in vitro is through direct
action on the Na/K-ATPase oxidant amplification loop, improving the redox biology of the
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adipocyte. This subsequently changes adipokine and cytokine secretion from the adipocyte,
which may have ramifications on systemic inflammation in our in vivo model. This further
confirms the role of adipocytes in obesity and its comorbidities is much more important than
previously determined.
Obesity is characterized as a disease of inflammation and is often characterized with high
levels of oxidative stress and inflammation. Plasma levels of inflammatory markers TNFα, IL-6,
and MCP-1 (along with leptin) were significantly reduced in lenti-adiponectin-GFP-NaKtide
treated animals (Figure 27), indicative of a peripheral effect from treating adipocytes
specifically. Treatment with lenti-adiponectin-GFP-NaKtide resulted in significant phenotypic
changes of adipocytes in visceral fat. First, there was a significant increase in cell number and
decrease in cell size in animals treated with lenti-adiponectin-GFP-NaKtide. These
morphological changes point to healthier adipocytes. Western blot analysis of visceral fat treated
with lenti-adiponectin-GFP-NaKtide showed decreases in FAS, PPARγ, and MEST, indicating a
decrease in adipogenesis. mRNA levels of leptin and TNFα were also improved in the adipose
tissue itself, further indicating a more metabolically healthy phenotype.
While it has been shown before that Na/K-ATPase signaling has an impact in obesity and
adipogenesis (Bartlett, Miller, Thiesfeldt, Lakhani, Shapiro, et al., 2018; Sodhi et al., 2015;
Sodhi et al., 2018; Sodhi et al., 2017), this work is novel in the fact that it investigates
specifically Na/K-ATPase signaling in the adipocyte itself by use of the lentiviral vector and
ouabain. Specific stimulation of the pump had not yet been investigated, and this information
lends to the hypothesis that the adipocyte Na/K-ATPase plays a larger role in the prognosis of
obesity.
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In our in vivo model, genes and proteins related to mitochondrial biogenesis and
“browning” of adipose tissue were significantly downregulated in mice fed a WD, but upon
treatment with lenti-adiponectin-GFP-NaKtide peroxisome proliferator-activated receptor
gamma coactivator 1 alpha (PGC1α), mitofusion 1 and 2 (MFN1 and 2), and NAD-dependent
deacetylase sirtuin-3 (Sirt3) were all significantly increased. There is accumulating evidence
suggesting that adipocyte mitochondria might play an important role in the development of
dysfunctional adipocytes and our results suggest this is at play, as well as increased
mitochondrial biogenesis (Boudina & Graham, 2014).Third, energy expenditure and oxygen
consumption were significantly improved in the lenti-adiponectin-GFP-NaKtide treated group.
Obesity is a known inducer of oxidative stress, and increases in ROS are known to
increase Na/K-ATPase signaling and thus the Na/K-ATPase oxidant amplification loop (Bartlett,
Miller, Thiesfeldt, Lakhani, Khanal, et al., 2018; P. T. Shah et al., 2016; Yan et al., 2013).
Protein carbonylation is a marker of ROS, and in WD-fed mice there are significant increases of
ROS (Figure 26). In the lenti-adiponectin-GFP-NaKtide treated mice there is a reduction in ROS
and activation of c-Src. Phosphorylated Src is a marker of Na/K-ATPase signaling and is
responsible for downstream signaling pathways and activation of other signaling cascades such
as Raf/Ras, NOX, and increased ROS as well (Z. Xie, 2003; Yan et al., 2016).
Our results showed that expression of the α1 subunit of the Na/K-ATPase was
significantly downregulated in visceral fat. It has been shown previously that oxidative stress can
induce endocytosis of α1 and increases in ROS oxidize the α1 subunit which also promotes
degradation of the Na/K-ATPase (H. Cai et al., 2008; J. Liu et al., 2004; Yan et al., 2016). Some
of the endocytosed α1 is recycled to the surface, while some is destroyed through endosomal,
proteolytic, and proteosomal pathways; previous evidence has shown that oxidative damage
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increases the degradation of the Na/K-ATPase in these pathways and impairs the cells ability to
recycle α1, and ROS can accelerate degradation of the Na/K-ATPase (W. H. Huang et al., 1992;
W. H. Huang et al., 1994; Kim & Akera, 1987; J. Liu et al., 2012; Thevenod & Friedmann,
1999). Hence, we propose that increased oxidative stress induced by WD leads to impaired
ability of the adipocyte to successfully regenerate or recycle previously endocytosed α1 and in
turn increases the amount of oxidized α1 further promoting endocytosis and degradation, leading
to a decrease in total α1 expression in mice fed a WD. As NaKtide expression attenuated the
decrease in α1 expression as well as the oxidant stress associated with WD, it is suggested that
the aforementioned oxidant stress plays a role in the observed decrease in α1 expression seen
with WD (Figure 26). This role, as stated before, is to temper the oxidant stress of the adipocyte
and turn the adipocyte towards a more balanced pro-and anti-inflammatory state. Treatment with
lenti-adiponectin-GFP-NaKtide also blocked Na/K-ATPase-regulated Src activation in mice fed
a WD (Figure 26). Further, as discussed previously, there may be a phenotypic switch from α1 to
α2 in the adipocytes to compensate for impaired pumping function; this switch is supported by
increased α2 in our in vivo study (Figure 26). Our findings suggest a crucial role of the Na/KATPase oxidant amplification loop in adipocytes that can be implicated in obesity.
Studies in mouse models of obesity have shown that increased oxidative stress in plasma
is due to increased ROS and cytokine production from dysfunctional adipocytes (Furukawa et
al., 2004; Le Lay et al., 2014). Furthermore, several metabolic parameters that are dysregulated
in obesity, including hyperglycemia, insulin resistance, and hyperlipidemia, also contribute to
and amplify systemic oxidative stress (Vincent & Taylor, 2006). Blocking Na/K-ATPase
signaling in the adipocytes ameliorated WD-induced dyslipidemia and insulin resistance
(Gutierrez et al., 2009; Sodhi et al., 2017). Moreover, the increase in plasma levels of leptin and
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inflammatory cytokines (i.e., IL-6, TNFα, and MCP-1) in mice fed a WD was attenuated by
NaKtide expression in adipocytes (Figure 27). This suggests a central role of the Na/K-ATPase
signaling loop within adipocytes in the development of obesity and systemic oxidative stress, and
the potential to improve obesity-related conditions in other organs by blocking this signaling.
Our results suggest a central role for the Na/K-ATPase oxidant amplification loop within
adipocytes in the pathogenesis of obesity induced by a WD. Moreover, expression of NaKtide
prevented WD-induced neurodegenerative effects (Figure 28); this is the first study implicating
the role of obesity and impaired Na/K-ATPase signaling in neurodegenerative disorders and may
shed light on the complex interplay between obesity and disorders such as Alzheimer’s disease.
It appears that targeting the Na/K-ATPase oxidant amplification loop may be promising in terms
of efficacy for treatment of adiposity and many related diseases while limiting off-target effects.
We also note that other consequences of obesity such as insulin resistance were attenuated by
adipocyte NaKtide expression. If these findings can be confirmed in humans, a number of
therapeutic strategies might be envisioned ranging from surgical control of fat mass, molecular
biological strategies described in this report to simple dietary manipulations. These data suggest
that adipocyte derived cytokines play an essential role in the development of obesity induced by
a WD and that targeting adipocyte Na/K-ATPase signaling may serve as an effective therapeutic
strategy.
Conclusions and Future Directions
Together, our results suggest a central role for the Na/K-ATPase oxidant amplification
loop within adipocytes in the pathogenesis of diet induced obesity. It appears not only that
targeting the Na/K-ATPase oxidant amplification loop may be promising but restricting
interventions to the adipocyte may have important clinical implications. If these findings can be
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confirmed in humans, several therapeutic strategies might be envisioned ranging from surgical
control of fat mass, molecular biological strategies described in this report to simple dietary
manipulations. This area of research is crucial given the prevalence of obesity currently seen not
only in the United States, but worldwide; as the prevalence of obesity increases, it is paramount
to note that the incidence of comorbidties such as insulin resistance, metabolic syndrome,
NASH, etc., are going to increase as well. By finding a suitable therapeutic target that can limit
the off-hand effects seen with some current obesity treatments, we will not only be able to limit
negative side effects, but also limit the incidence of comorbidities as well.
Future directions will explore the implications of manipulating adipocyte redox biology
in other disease states that have been explored in our lab, such as uremic cardiomyopathy and
atherosclerosis. Further, more specific attention will be given to investigate other changes (i.e.
NASH and neurodegeneration) noticed in the in vivo models with treatment of lenti-adiponectinGFP-NaKtide to add more to the story of the adipocyte’s role on whole body homeostasis and
redox signaling.
We have clearly demonstrated that the Na/K-ATPase amplification loop has an impact on
adipogenesis. ROS amplification can occur through this pathway, and significantly increase
adipogenesis and further increase Na/K-ATPase signaling. These phenomena suggest that the
Na/K-ATPase oxidant amplification loop may serve as a potential target in dysfunctional redox
states and oxidative stress therapies associated with obesity.
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APPENDIX B: LIST OF ABBREVIATIONS


[Ca2+]i: Intracellular calcium concentration



[K+]i: Intracellular potassium concentration



[Na+]i: Intracellular sodium concentration



ACE: angiotensin converting enzyme



ADP: adenosine diphosphate



AM: Adipogenic Media



Ang II: angiotensin II



ANOVA: Analysis of variance



ApoE: Apolipoprotein E



ARF: Animal Resource Center



AT1: Angiotensin Type 1



AT2: Angiotensin Type 2



ATMs: Adipose tissue macrophages



ATP: Adenosine triphosphate



BAPTA-AM: 1,2-Bis(2-aminophenoxy)ethane



BAT: brown adipose tissue/brown adipocytes



Ca2+ : calcium



Cav-1: caveolin-1



CCBYNC 4.0: Creative Commons Attribution Non Commercial License



CEBPα: CCAAT Enhancer Binding Protein Alpha



CD2: α1 CD2 segment



CD36: cluster of differentiation 36
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CDC: Center for Disease Control



CTS: cardiotonic steroids



Cys-46: cystein residue 46



D2: dopamine receptor 2



DMEM: Dulbecco’s Modified Eagle Medium



DNA: deoxyribonucleic acid



DNP: 2,4, dinitrophenyl



DNPH: 2,4, dinitrophenylhydrazine



EBF2: Early B Cell Factor 2



EGTA: ethylene glycol-bis(β-aminoethyl ether)



ELISA: enzyme linked immunosorbent assay



ER: Endoplasmic reticulum



F4/80: EGF-like module-containing mucin-like hormone receptor-like 1



FAS: fatty acid synthase



FBS: fetal bovine serum



FFA: free fatty acids



FGF21: Fibroblast growth factor 21



GAPDH: Glyceraldehyde 3-phosphate dehydrogenase



GFP: green fluorescent protein



Gln 434:glutamine residue 434



GLUT4: glucose transporter type 4



H+ : Hydrogen ions



H&E: hematoxylin and eosin staining
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H202: hydrogen peroxide



HFD: high fat diet



HO-1: heme oxygenase 1



IHC: immunohistochemistry



IL-1β: interleukin 1 beta



IL-4: interleukin-4



IL-6: interleukin-6



IL-10: interleukin 10



IL-13: interleukin-13



IL-1R: interleukin 1 receptor



iNOS: Nitric oxide synthase family



IP: intraperitoneally



IP3R: inositol 1,4,5-trisphosphate receptors



IRS1: insulin receptor substrate 1



K+ : potassium



KD: cSrc Kinase Domain



LDH: lactate dehydrogenase



LKK: Binding site for α1 and IP3R NH2 terminuses



LPL: lipoprotein lipase



MBG: marinobufagenin



MCP-1: monocyte chemoattractant protein-1



MEK: methyl ethyl ketone



MEST: mesoderm specific transcript gene
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MFN1: Mitofusin 1



MFN2: Mitofusin 2



Mg+ : magnesium



mitoKATP: mitochondrial ATP-sensitive K+ channels



MM: Maintenance Media



MMP2: matrix metalloproteinase 2



MMP9: matrix metalloproteinase 9



mRNA: Messenger RNA



Myf5+: myogenic factor 5



Na+ : sodium



NAC: N-acetylcysteine



NaCl: Sodium Chloride



NADPH: nicotinamide adenine dinucleotide phosphate



NASH: nonalcoholic steatohepatitis



NCX: Na+/Ca2+



ND1: α1 ND1 segment



NFκB: nuclear factor kappa light chain enhancer of activated B cells



NHE3: Sodium–hydrogen antiporter 3



NIH: National Institutes of Health



NKAL: Na/K-ATPase oxidant amplification loop



NO: Nitric oxide



NOS: Nitric oxide synthase family



Nos2: Nitric oxide synthase family
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OCT: optimal cutting temperature compound



OSA: Obstructive SLeep Apnea



Pax 3: Paired box protein 3



Pax7+: paired box protein



PBS: phosphate buffered saline



PDGFRα: platelet derived growth factor receptor alpha polypeptide



PFA: paraformaldehyde



PGC1α: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha



PLC-ᵞ: phospholipase C-ᵞ



PNx: partial nephrectomy



PPAR-γ: Peroxisome proliferator-activated receptor gamma



PRDM16: PR-domain contain 16 protein



Pro222: Proline 222



Pro224: Proline 224



PSD95: postsynaptic density protein 95



R2: R-squared



RAAS: Renin-angiotensin aldosterone system



RBCs: Red blood cells



RIPA: Radioimmunoprecipitation assay buffer



RNA: ribonucleic acid



RNS: reactive nitrogen species



ROS: reactive oxygen species



RT-PCR: Reverse transcription polymerase chain reaction
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SE/SEM: Standard Error/Standard Error of the Mean



Ser 415: serine residue 415



SERCA: sarco-endoplasmic reticulum Ca2+



SH2: cSrc SH2



Sirt1: Sirtuin 1



Sirt 3:NAD-dependent deacetylase sirtuin-3



SNS: Sympathetic Nervous System



TAT: twin-arginine translocation



TH: Tyrosine hydroxylase



Thr224: Threonine 224



TLR4: Toll like receptor 4



TNFα: tumor necrosis factor α



TUNEL: terminal deoxynucleotidyl transferase dUTP nick end labeling



Tyr 418: Tyrosine residue 418



UCP1: uncoupling protein 1



UUO: unilateral ureteral obstruction



WAT: White adipose tissue/white adipocytes



WD: western diet



WHO: World Health Organization
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